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This thesis entails research on the compression and plasticity of old-age mortality during 
the epidemiologic transition. The first chapters study the start of the epidemiologic 
transition in rural Ghana and describe the changes in mortality. This is followed by 
chapters on the compression of mortality and morbidity during the transition in Japan 
and the Netherlands. Finally, the last chapters concern the plasticity of mortality at old 
age. Studying old-age mortality during the epidemiologic transition is of great importance 
now that an increasing number of people reach old-age. 
Life expectancy has increased all over the world from an average life expectancy of 
approximately 40 years before the epidemiologic transition to an average life expectancy 
that exceeds 80 years in post transitional countries today.[1] This major success in 
improving life expectancy was accompanied by a shift from child to old-age mortality and 
from infectious to non-infectious diseases.[2] The process of these mortality changes are 
described in the epidemiologic and demographic transition theories.
In 1971, it was Omran who first extensively described the different stages of the 
epidemiologic transition. He defined three classical stages, the first with high and 
fluctuating mortality, with an average life expectancy at birth varying between 20 and 40 
years. This was followed by the second stage, when mortality declined at first gradually 
and then accelerated as soon as epidemic peaks became less frequent. This induced an 
increase in life expectancy at birth of 30 to 50 years on average. During the last stage 
mortality declined further, resulting in an average life expectancy that first exceeded 50 
years. The first two stages were dominated by infectious diseases, whereas in the last 
stage the major cause of death was due to chronic diseases. The epidemiologic transition 
has been described as a sequential process of mortality changes.[2] 
Now that mortality rates at old age are continuously on the decline, it is questioned 
whether the extra years are lived in good or in ill health.[3,4] How patterns of health and 
disease have evolved in the past and will evolve in the future is studied extensively. Part 
of this debate is centred around the compression of mortality and morbidity at old age. 
 
The compression of mortality at old age indicates the distribution of the age at death in a 
population.[5] A population with no mortality compression at all would have completely 
age independent mortality risks. By contrast, maximum mortality compression would 
imply that a whole population would die simultaneously at the same age. Over the last 
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decades, there has been compression of old-age mortality, however, it is debated if the 
compression of mortality will reach a limit.[6,7] There is even more debate about the 
compression of morbidity, which precedes mortality. Some argue that our longer lives 
bring worsening health with an expansion of morbidity.[6,10,11] On the contrary, others 
believe that morbidity has also been compressed, even at old age.[9,10] 
Finally, it is disputed whether mortality at old age is biologically fixed. The role of early 
life environment on old-age mortality is well documented. Infectious diseases and poor 
nutrition early in life have been linked with mortality in old age.[11-13] By contrast, there 
is controversy about the role of direct or late life effects on old-age mortality. Old-age 
mortality is often still thought to be fixed and it is generally believed that no significant 
reduction in mortality can be expected from environmental improvements later in life.
[14] Some studies however, did show a direct health benefit and mortality reduction 
when introducing interventions at old age.[15-17] The debate of the plasticity of old-age 
mortality is of prime importance for the growing population of elderly and public health. 
Aim of this thesis
To study the compression and the plasticity of old-age mortality during the epidemiologic 
transition. 
Outline of this thesis
Chapter one provides a general introduction to the research in this thesis and describes 
the three main topics of this thesis: the epidemiologic transition, the compression of 
mortality and the plasticity of old-age mortality. The next two chapters are related to the 
epidemiologic transition. In chapter two we study the role of socioeconomic status and 
drinking water source on mortality and fertility decline at the start of the epidemiologic 
transition in rural Ghana. In addition we studied cause-specific mortality trends by 
making use of Verbal Autopsies. Chapter three covers a study on seasonal variation in 
mortality and cause-specific mortality in rural Ghana during the epidemiologic transition. 
We examine variation in mortality depending on the season and on the month of death. 
In the following chapter four we study the compression of mortality at old age during 
the epidemiologic transition in Japan and the Netherlands. Next to the compression of 
mortality, we study the compression of morbidity in chapter five. We decompose the 
trends in old-age mortality into trends of different morbidity measures. We examine 
the sex differences in these different measures of healthy life expectancy and discuss 
the compression of morbidity during the epidemiologic transition in the Netherlands. 
Following on the previous chapter, we argue that the increase in life expectancy is 
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accompanied by improved health in chapter six. In the final chapters we study different 
determinants of the plasticity of mortality at old age. First, in chapter seven, we study the 
plasticity of old-age mortality, in an experiment of nature in Japan which experienced an 
accelerated epidemiologic transition. Next, we examine another example of the plasticity 
of old-age mortality in a study on the effect of high intensive physical exercise on mortality 
risk in late life. We challenge the view that more physical activity is always better when it 
comes to health benefits. In chapter eight we test this hypothesis in a cohort of former 
Olympic athletes from different disciplines with various levels of physical intensity. 
Furthermore in chapter nine, we study the life expectancy of various historical artists 
compared to the elite in the Low Countries. Finally, we summarize the implications of 
our main findings concerning the compression and plasticity of old-age mortality and 
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DETERMINANTS OF THE EPIDEMIOLOGIC 
TRANSITION IN RURAL AFRICA: 
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Many African countries experience a protracted epidemiologic transition that is different 
from the classical transition in western societies. The factors driving this protracted 
transition are largely unknown. In Northeast Ghana, we had the opportunity to study 
an ongoing epidemiologic transition and disentangle the effects of socioeconomic 
status and drinking water source. For nine years, we followed a cohort of almost 30,000 
individuals for mortality and fertility rates. In addition, we obtained the causes of death by 
verbal autopsy, according to the standards of the World Health Organization. We found 
that mortality rates decreased by –5.0% annually (p<0.001) and that the main cause 
of death shifted from infectious diseases to non-infectious diseases (p=0.014). General 
fertility rates decreased by –12.7% annually (p<0.001) and child-women ratios decreased 
by –11.9% annually (p<0.001). There was no difference in the declines in mortality and 
fertility depending on socioeconomic status or the use of (un)improved drinking water 
source. Hence, factors other than socioeconomic status and drinking water source must 
drive the observed declines in mortality and fertility during the protracted epidemiologic 
transition. Identifying the specific determinants of the ongoing epidemiologic transition 
is of importance, as these identify targets to further improve public health in rural African 
countries.
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INTRODUCTION
Since the description by Omran in 1971, the course of the epidemiologic transition is 
well known.1 According to his model, the epidemiologic transition is a process with a 
decline in mortality followed by a decline in fertility. The first stage is characterised by 
pre-transitional patterns of health and disease, with pestilence and famine leading to 
high and fluctuating mortality together with high fertility. The average life expectancy at 
birth is around 20 to 40 years. During the second stage, mortality gradually declines as 
epidemic outbreaks become less frequent. The average life expectancy increases to 30 
to 50 years. During the last stage, fertility rates start to decline and mortality is further 
reduced. Degenerative and man-made diseases prevail and the average life expectancy 
exceeds 50 years.
It is debated how currently developing countries, including those in rural Africa, 
experience the epidemiologic transition.2-5 Many developing countries have started to 
experience a decline in mortality, but also in fertility.6,7 Contrary to the classical sequential 
stages described above, these countries suffer from the coexistence of infectious and 
degenerative diseases, which is denominated as polarisation.3,5,8 It has therefore been 
proposed to adopt a protracted model for the epidemiologic transition in developing 
counties, in which the classical stages overlap.1,2,5 In addition, factors that have played an 
essential role in the classical epidemiologic transition, such as improvements in hygiene, 
access to improved drinking water, and socioeconomic status,1 have been shown 
to determine the survival probability in rural Africa.9,10 However, it is unclear whether 
these factors drive the declines in mortality and fertility during the current protracted 
epidemiologic transition.2,6,7
We had the opportunity to study an ongoing epidemiologic transition in rural Africa. 
In one of the least developed areas of Ghana, we followed a cohort of almost 30,000 
inhabitants for nine years and registered survival and fertility. In addition, we obtained 
the causes of death by verbal autopsy. We were able to disentangle the effects of 
socioeconomic status and drinking water source, which are independently distributed in 
the area, on the changes in mortality and fertility.
METHODS
Ethics statement
As the majority of the study participants were unable to read and write, informed consent 
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was obtained orally. A consent form was read out to the participants in their local 
language, explaining the purpose and procedure of the study. For the verbal autopsies, 
the consent form from the verbal autopsy protocol of the World Health Organization 
(WHO) was read out. Consent was registered in the form of a thumb print. The entire 
procedure, including the text of the consent form, was approved by the Ethical Review 
Committee of the Ghana Health Service, the Medical Ethical Committee of the Leiden 
University Medical Center in Leiden, the Netherlands, and by the local chiefs and elders 
in the research area.
Research area and study population
This study was conducted in the Garu-Tempane District in the Upper East Region of 
Ghana. A map of the research area is provided in Figure 1. The Upper East Region is one 
of the least developed regions of Ghana, contrasting sharply with the more urbanised 
Figure 1. Map of the research area in the Garu-Tempane District in the Upper East Region in 
Ghana. Large purple circles denote improved drinking water sources, large green circles denote 
unimproved drinking water sources. Small circles denote households of which the colours indicate 
their primary drinking water source being improved or unimproved. Geographical and hydrological 
data were provided by CERGIS, University of Ghana in Legon, Accra, Ghana.
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and affluent southern parts of the country.11,12 The majority of the population are farmers, 
who execute the total agricultural process manually and without proper means of 
transportation, irrigation, and electricity.9,13 The local economy is partly according to the 
Barter system, in which goods are directly exchanged for other goods or services.11,12 
Up to half of the population has not received any education.11,12 Access to medical care 
is limited; most people rely on the aid of traditional healers.11,12,14 Infectious diseases, 
such as malaria, meningitis, typhoid fever, and acute respiratory infections, are highly 
endemic and constitute the main causes of death.14-17
We kept a demographic registry of all inhabitants of a specified geographic area in the 
Garu-Tempane District measuring approximately 375 km2 and comprising 32 villages. 
From 2002 through 2011 we visited the research area every year. Annual migration 
relative to the total study population was estimated to be 2% into and 1% out of the 
research area.18
Socioeconomic status
We measured the socioeconomic status of each household in 2007 based on the 
Demographic and Health Survey (DHS) method. In short, a DHS wealth index was 
calculated by listing the household property items of most value, such as cattle, bicycles, 
and iron roofing. The value of these items in US$ was estimated and summed for each 
household. For each individual, the socioeconomic status was classified as being below 
or above average according to the DHS wealth index of his household in 2007 split by the 
median. Detailed descriptions of this method have been published earlier.9
Water source
The main drinking water source was registered for each household in 2007. From around 
1970 onwards, water boreholes were introduced throughout the research area by foreign 
non-governmental organisations (NGOs), independently of the socioeconomic status of 
surrounding households. Besides, a substantial part of the households depend on water 
from open wells and small rivers. Water from boreholes contains less pathogens and is, 
therefore, a safer source of water than water drawn from open wells and rivers, in which 
the pathogen content is higher.10 In line with the classification of the WHO, we classified 
individuals living in 2007 in a household with access to a borehole as having access to an 
improved water source and those living in 2007 in a household with access to only open 




For each year of follow-up we constructed life tables. The population size at the midpoint 
of each year of follow-up was estimated as the average of the two population sizes 
registered at the beginning and at the end of the year. Per year of follow-up, mortality 
rates were calculated as the registered number of deaths divided by the corresponding 
mid-year population. Since only live children were registered and the registry was updated 
with one-year intervals, mortality was missed for children born and deceased between 
two visits. Individuals below one year of age were therefore excluded from the analyses. 
Mortality rates were standardised to the population’s distribution over age and sex in 
2003.
Verbal autopsies
To obtain causes of death, we performed interviews in 2011 using validated verbal 
autopsy questionnaires from the WHO.20-24 We translated the English questionnaires into 
the two major local languages, Bimoba and Kusaal. To test whether the questionnaires 
were translated correctly, we performed back-translations into English by independent 
translators. In cases of discrepancy, the final translation was decided upon after group 
discussions with native speakers and medical experts. In the research area, it is customary 
that one relative or caretaker from the same household closely cares for an ill or dying 
individual. The verbal autopsy interviews were principally performed with these relatives 
or caretakers of the deceased individuals. For deceased children, this concerned mostly 
the mother; for deceased elderly, this concerned generally one of the children living in the 
same household as the deceased individual.
From the total of 1,406 deaths, we were able to complete verbal autopsies for 1,263 
(90%), of which 1,253 from the age of 1 onward. Verbal autopsy interviews could not 
be performed in 10% of the cases, mainly due to absence of an appropriate respondent 
at the time of the field visit. Following the guidelines of the WHO,23,24 two physicians, 
blinded for each other’s assessment, independently assigned causes of death to each 
verbal autopsy. If the assigned causes of death differed between the first two physicians, 
a third physician gave an independent assessment, not blinded for the assessment of 
the first two physicians. A cause of death was obtained if at least two of the physicians 
agreed; otherwise the cause of death was classified as unspecified. The causes of death 
were coded according to the International Classification of Diseases (ICD) VA-10 coding, 
as prescribed by the WHO verbal autopsy method.23,24
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Fertility
We calculated two period measures of fertility for each year of follow-up. As the study 
population is polygamous with one man marrying up to four women, we calculated 
fertility measures for both females and males. The general fertility rate (GFR) was 
calculated by dividing the number of newborns by the number of females or males aged 
19 to 44. The child-adult ratio (CAR) was calculated by dividing the number of children 
aged up to 5 by the number of females or males aged 19 to 49.
Statistical analyses
To explore determinants of the absolute mortality over the entire period of follow-up, 
we used Cox regression with left truncation of the longitudinal individual survival data. 
Changes in mortality rates over calendar years were determined and tested by Cox 
regression with calendar year as a covariate. Changes in the relative proportions of causes 
of death over calendar years were determined and tested by logistic regression with 
calendar year as a covariate. Changes in fertility rates over calendar years were determined 
and tested by Poisson regression with calendar year as a covariate and robust Huber-
White sandwich estimation of variance. The analyses were also separately performed in 
three age groups representing children, adults, and elderly and after stratification by sex, 
socioeconomic status, and drinking water source. The analyses were performed in IBM 




Table 1 gives the characteristics of the study participants at baseline in 2002 and at 
the end of follow-up in 2011. During the full period of follow-up we registered 29,642 
individuals from 1,719 different households with a median (interquartile range) individual 
follow-up of 8 (4–9) person-years. During this period we observed 4,069 newborns and 
1,406 deaths.
Table 1. Characteristics of the study population
Year 2002 2011
Total number of individuals 17,178 24,048
Sex
     Male 8,191 (47.7%) 11,658 (48.5%)
     Female 8,987 (52.3%) 12,390 (51.5%)
Tribe
     Bimoba 11,168 (65.0%) 15,991 (66.5%)
     Kusasi 4,694 (27.3%) 6,438 (26.8%)
     Other 1,316 (7.7%) 1,608 (6.7%)
Socioeconomic status
     Below average 5,762 (33.5%) 8,251 (34.3%)
     Above average 11,088 (64.5%) 15,154 (63.0%)
Water source
     Unimproved 3,254 (18.9%) 4,530 (18.8%)
     Improved 13,913 (81.0%) 19,020 (79.1%)
Data are given as numbers with percentages.
Figure 2 shows the age distributions of the study population at the start of the follow-up 
period in 2002 and at the end in 2011. A major shift can be seen in the constitution of the 
population, especially in the youngest age groups. In 2002, the group of 0-9 years made 
up 44.3% of the total male population and 37.6% of the total female population. In 2011 
this had decreased to 27.1% and 25.9%, respectively.
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The absolute level of mortality over the entire follow-up period was dependent on age, 
sex, socioeconomic status, and water source. Mortality was higher in individuals of male 
sex (+41.3%, p<0.001), with a socioeconomic status below average (+30.7%, p<0.001), 
and for those drinking from an unimproved water source (+21.1%, p=0.003). The effects 
of sex, socioeconomic status, and water source on mortality were mutually independent 
and did not interact (all p>0.05). The effects of socioeconomic status and water source 
on mortality did not differ between the periods of follow-up before and after 2007 
(Supplementary Table 1).
Figure 2. The sex-specific distributions over age groups of individuals in the study population in 
2002 (upper pyramid) and 2011 (lower pyramid).
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Supplementary Table 1. Socioeconomic status and water source as determinants of absolute 
mortality during 2002–2007 and during 2007–2011
Difference in mortality (95%CI)
2002–2007 2007–2011 p value
Socioeconomic status
     Below average +32.9% (+15.3; +103.8) +24.8% (+5.7; +47.4) 0.696
     Above average Ref. Ref.
Water source
     Unimproved +25.7% (+6.6; +48.4) +15.6% (–5.3; +41.2) 0.579
     Improved Ref. Ref.
The difference in mortality between groups of socioeconomic status and water source have been 
calculated adjusted for sex as relative differences compared to the reference groups and are given 
with a 95% confidence interval (95%CI). The p values for interaction indicate that these effects do 
not differ between the periods 2002–2007 and 2007–2011. Ref.: reference group.
Table 2 shows the causes of death during the follow-up period from 2003 through 2011 as 
registered by verbal autopsy. Both the absolute number of deaths and the prevalences of 
infectious causes of death relative to those of non-infectious causes of death decreased 
during the period of follow-up.
Table 2. Causes of death during 2003–2011 as registered by verbal autopsy
Cause of death 2003–2005 2006–2008 2009–2011
Infectious and parasitic disorders 237 (51.5%) 195 (47.4%) 169 (44.2%)
Neoplasms 9 (2.0%) 10 (2.4%) 14 (3.7%)
Nutritional and endocrine disorders 3 (0.7%) 3 (0.7%) 0 (0.0%)
Disorders of the circulatory system 12 (2.6%) 9 (2.2%) 13 (3.4%)
Respiratory disorders 2 (0.4%) 3 (0.7%) 4 (1.0%)
Gastrointestinal disorders 20 (4.3%) 21 (5.1%) 20 (5.2%)
Renal disorders 1 (0.2%) 1 (0.2%) 0 (0.0%)
Mental and nervous system disorders 5 (1.1%) 3 (0.7%) 2 (0.5%)
Pregnancy- and childbirth-related disorders 3 (0.7%) 9 (2.2%) 7 (1.8%)
External causes 28 (6.1%) 36 (8.8%) 25 (6.5%)
Other specified causes 3 (0.7%) 0 (0.0%) 0 (0.0%)
Unspecified causes 137 (29.8%) 121 (29.4%) 128 (33.5%)
Total 460 (100%) 411 (100%) 382 (100%)
Data are given as numbers with percentages. Causes of death are categorised according to the 
International Classification of Diseases (ICD) VA-10 coding, as prescribed by the WHO.22,23
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Figure 3A shows the decline in age-standardised mortality rates during the follow-up 
period from 2002 through 2011 for males and females. Mortality rates declined for 
males from 1,645 to 868 per 100,000 person-years and for females from 1,137 to 534 per 
100,000 person-years. The overall mortality rate declined by –5.0% per calendar year 
(p<0.001). Mortality rates for infectious causes of death declined by –6.8% per calendar 
year (95%CI: –9.8 to –3.8, p<0.001) and mortality rates for non-infectious causes of 
death declined by –3.6 per calendar year (95%CI: –6.2 to –0.8, p=0.01). As shown in 
Figure 3B, during the follow-up period, the major cause of death shifted from infectious 
to non-infectious diseases (p=0.014).
Figure 3. 
A. Age-standardised sex-specific 
mortality rates per 100,000 
person-years (py) over calendar 
years.
B. Relative prevalences of causes 
of death, classified as infectious 
or non-infectious, over calendar 




Table 3 shows the annual declines in mortality rate depending on age, sex, socioeconomic 
status, and water source. We studied the interaction between these determinants and the 
annual decline in mortality rate. There was no difference in the annual mortality decline 
between the age groups, sexes, groups of socioeconomic status, or types of water source 
(all p>0.05). Also, when studying the interaction between the various determinants and 
mortality in deaths due to infectious causes or non-infectious causes separately, no 
interaction was found.
Table 3. Determinants of the decline in mortality during 2002–2011
Annual decline in 
mortality rate
95%CI p value
Overall –5.0% (–7.0; –2.9) < 0.001
Age group
     Ages 1–14 years –4.2% (–7.7; –0.5) 0.026
     Ages 15–64 years –6.6% (–9.8; –3.3) < 0.001
     Ages 65+ years –3.9% (–7.4; –0.2) 0.038
Sex
     Male –4.8% (–7.5; –2.1) 0.001
     Female –5.2% (–8.2; –2.1) 0.001
Socioeconomic status
     Below average –5.3% (–8.4; –2.1) 0.001
     Above average –3.6% (–6.2; –0.8) 0.012
Water source
     Unimproved –6.5% (–10.7; –2.2) 0.004
     Improved –4.4% (–6.7; –2.1) < 0.001
The annual decline has been calculated as the relative change in the hazard ratio and is given with 
a 95% confidence interval (95%CI). Differences in the annual decline in mortality rate between age 
groups, groups of socioeconomic status, and groups of water source are non-significant.
Table 4 shows the annual declines in fertility rates. The general fertility rate (GFR) is 
the number of newborns per 1,000 females or males aged 19 to 44. The GFR decreased 
by –12.7% per year for females and by –11.9% per year for males. The child-adult ratio 
(CAR) is the number of children aged below 5 per 1,000 females or males aged 19 to 49. 
The CAR decreased by –15.0% per year for females and by –14.0% per year for males 
(all p<0.001). We observed no differences in these annual declines between groups of 
socioeconomic status or types of water source (all p>0.05).
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Table 4. Determinants of the decline in fertility during 2002–2011








Overall –12.7% (–16.9; –8.4) < 0.001 –11.9% (–12.5; –11.2) < 0.001
Socioeconomic status
     Below average –13.9% (–20.0; –7.5) < 0.001 –12.6% (–13.4; –11.8) < 0.001
     Above average –12.6% (–15.7; –9.4) < 0.001 –11.8% (–12.4; –11.3) < 0.001
Water source
     Unimproved –11.0% (–16.8; –4.8) 0.001 –12.0% (–13.1; –11.1) < 0.001
     Improved –13.6% (–15.3; –9.7) < 0.001 –12.1% (–12.6; –11.5) < 0.001
Males
Overall –15.0% (–19.1; –10.8) < 0.001 –14.0% (–14.8; –13.2) < 0.001
Socioeconomic status
     Below average –15.6% (–21.4; –9.4) < 0.001 –14.4% (–15.3; –13.4) < 0.001
     Above average –15.3% (–15.3; –12.1) < 0.001 –14.3% (–15.0; –13.7) < 0.001
Water source
     Unimproved –14.1% (–19.4; –8.3) < 0.001 –14.9% (–15.9; –13.8) < 0.001
     Improved –15.7% (–19.4; –11.8) < 0.001 –14.1% (–14.7; –13.4) < 0.001
The annual decline has been calculated as the relative change in the general fertility rate or the 
child-adult ratio and is given with a 95% confidence interval (95%CI). Differences in the annual 
decline in mortality rate between age groups, groups of socioeconomic status, and groups of water 
source are non-significant.
Figure 4 shows the annual decline in fertility rates during the follow-up period from 2002 
through 2011 for males and females. Figure 4A displays the decrease in the GFR from 236 
to 60 newborns per 1,000 males and from 186 to 56 newborns per 1,000 adult females. 
Figure 4B displays the decrease in the CAR from 1,459 to 454 children per 1,000 males 
and from 1,138 to 419 children per 1,000 females. During the follow-up period, the trends 
in fertility of males and females converged. When studying the interaction between 
sex and fertility decline, there was no interaction between sex and the decline in GFR 




A. General fertility rate as the number of newborns per 1,000 females or males aged 19 to 44 over 
calendar years. 
B. Child-adult ratio as the number of children aged up to 5 years (y) per 1,000 females or males 
aged 19 to 49 over calendar years. 
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DISCUSSION
This study describes the epidemiologic transition in rural Africa during a follow-up period 
of nine years. We observed declines in both mortality and fertility. At the same time, the 
main cause of death changed from infectious diseases to non-infectious diseases. These 
transitions were not dependent on socioeconomic status or drinking water source.
Different models have been proposed to describe the declines in mortality and fertility 
during the various stages of the epidemiologic transition.1,2 The validity of these theories 
highly depends on the time and place of a transition.1,6,7 The transition in currently 
developing countries, as described by the protracted transition model, is expected to 
differ in two ways from the classical transition, as has been experienced by the current 
industrialised countries. Firstly, while a decline in mortality is classically regarded as a 
prerequisite and precursor of a decline in fertility, these stages are not sequential but 
overlap in developing countries. Secondly, the classical transition is mainly driven by 
socioeconomic rather than medical factors, since a high socioeconomic status improves 
standards of living, health habits, hygiene, and nutrition.1 However, in developing 
countries, the role of socioeconomic status and hygiene remains unclear.
In line with the protracted transition model, we observed concurrent declines in mortality 
and fertility and a coexistence of infectious and non-infectious diseases, known as a 
double burden of disease.3,5,8 During the follow-up period we did not observe the start 
of the transition in the research area and our conclusions are confined to the follow-up 
period. Therefore, we cannot make inferences on the start of the declines in mortality 
and fertility and their relative timing. Furthermore, we observed that the male and 
female fertility trends converged during the period of follow-up. This finding could point 
to a decrease in the prevalence of polygamy, which would be in line with an ongoing 
epidemiologic transition.
It is tempting to hypothesise about possible elements that have contributed to the 
epidemiologic transition in rural Ghana. Previously, we have described socioeconomic 
status and water source as determinants of absolute mortality over age in our study 
population. Risk of mortality is increased for those with a low socioeconomic status and 
those who drink from unimproved water sources.9,10,25 Although socioeconomic status 
and water source determine survival, they did not relate to the declines of mortality and 
fertility during the epidemiologic transition. Possibly, these declines have started earlier 
in groups with a relatively high socioeconomic status or access to an improved water 
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source, so that the absolute levels of mortality differ, but the declines in mortality do not 
differ.
Importantly, socioeconomic status and water source have likely been stable factors in 
the research population. This assumption is supported by the fact that the effects of 
socioeconomic status and water source on mortality did not differ between different 
periods of follow-up. It has been shown that the heritability of socioeconomic status in 
pre-transitional societies is substantial, especially when material wealth is of relatively 
more importance than embodied or relational kinds of wealth, as is true for agricultural 
societies such as in this research area.26-29 In our study population, socioeconomic status 
has been primarily determined by material household property that is passed from 
parents to children, such as cattle, vehicles, and iron roofing.9,11,12 Migration has been 
related to rapid changes in socioeconomic status,30 but annual migration in this research 
area was low. In general, if socioeconomic status has changed for all groups in the 
research area, relative differences remain stable. Concerning water sources, households 
predominantly draw from the most nearby and easily accessible source. As improved 
water sources, boreholes have been constructed in the research area by western non-
governmental organisations from 1970 onward.10,18 Since then, new boreholes have 
scarcely been introduced. During our nine years’ presence in the research area, we only 
incidentally found a dysfunctional borehole. This is in line with our informal observation 
that the water infrastructure did not change significantly during this period. The use of 
boreholes as opposed to rivers and open wells is mainly dependent on their distances to 
the household. In line with this, we found no association between socioeconomic status 
and water source on the annual declines in mortality and fertility. In another district close 
to our research area, it has been documented that there is almost no relation between 
water source and socioeconomic status.31
It is possible that socioeconomic status does not contribute to the epidemiologic 
transition in this study population due to the local economic system, wherein goods 
are directly exchanged for other goods or services, according to the Barter system. For 
the transition to occur in such an economy, small-scale developments that raise the 
productivity of the agricultural sector and that facilitate the trade with other regions are 
more important, but are, at the same time, more difficult to record than material wealth.32 
Examples of such investments are the provision of land development techniques, means 
of transportation, and education. In our study population, these requisites have long 
remained deficient, but are slowly developing.9 There is little incentive to produce more 
food than locally needed, since crops are low in value and cannot be easily exported 
outside the area.
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It has been suggested that public health measures especially induce a transition in rural 
African countries.1,4,6,7,33-36 This could be true for our study population, where public health 
services have improved during the follow-up period. In 2003, a national health insurance 
was established. Its national coverage rose from 18% in 2006 to 62% in 2009.36 In our 
study population, its coverage rose from 4% in 2007 to 24% in 2011. People enrolled 
in this health insurance program are more prone to attend formal medical care.34,36 
Moreover, the coverage of immunisation has risen, thanks to vaccination programs 
for diphtheria, tetanus, pertussis, measles, hepatitis B, and polio. Furthermore, mass 
treatment of parasitic diseases has taken place in our research area.15 Such public health 
measures have probably been of benefit for the population in general, regardless of 
socioeconomic status and water source.
The epidemiologic transition in rural areas has several important implications for 
society. The coexistence of both infectious and non-infectious diseases is a double 
burden to public health. We have argued earlier that the absence of a sedentary lifestyle 
prevents the occurrence of cardiovascular disease in our study population.16 The 
progression of agricultural techniques and public health is likely to be accompanied by 
changes in lifestyle that strongly increase the risk of non-infectious diseases.2,37 Currently, 
the primary focus in rural areas is on cure, thereby neglecting prevention and care.2 
Moreover, developing countries have limited resources to establish an effective response 
to the double burden of disease.38 More knowledge on the epidemiologic transition, its 
underlying determinants, and the burden of disease can help rural African regions to 
develop more effective public health interventions.
A strength of this study was that follow-up was available for the entire population within 
the research area for a period of nine years. Consequently, the mortality and fertility 
measures that we have documented represent true outcomes for this population. A 
limitation of this study is that it lacks reliable information on the survival of children 
aged less than 1. To estimate mortality in this age group, we executed interviews in 
2011 and registered whether children had been born and died between our field visits 
in 2010 and 2011. From this, we estimated the mortality rate to be 3,313 per 100,000 
person-years. This number accords with the mortality rate of this age group as reported 
for the entire Upper East Region, being 3,300 per 100,000 births.12 Although we cannot 
draw conclusions about possible changes in mortality in this age group, this limitation 
does not undermine our conclusions for the other age groups. A further limitation is 
that we performed all verbal autopsy interviews in 2011. Hence, the recall period varied 
from 0 to 9 years. However, the percentages of uncompleted verbal autopsies and of 
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unspecified causes of death were distributed equally over the years. Next, declines in 
mortality and fertility were only related to socioeconomic status and water source. These 
two parameters were known for the entire population, contrary to other parameters 
measured in selected subgroups,10,16,17 and were strongly related to mortality.9,10,25 Finally, 
we lack some information on women’s fertility that would have been valuable to describe 
the epidemiologic transition, such as changes in age at first birth, time between births, 
parity, and cultural values related to fertility. 
In conclusion, in rural Ghana, mortality and fertility decline in parallel during the 
epidemiologic transition. Socioeconomic status and water source do not play a role in 
these declines. Studying the epidemiologic transition in developing countries can direct 
to specific public health interventions that can improve public health in these countries.
Authors’ contributions
FME, JJEK, DvB, UKE, and RGJW conceived the study and designed the study protocol; 
FME, JJEK, DvB, and UKE carried out the data collection; FME and JJEK carried out the 
analyses; all authors carried out the interpretation of the data; FME and JJEK drafted 
the manuscript; DvB, UKE, and RGJW critically revised the manuscript for intellectual 
content. All authors read and approved the final manuscript. RGJW is guarantor of the 
paper.
Acknowledgements
The authors are grateful for the dedicated work of the local assistance of the research 
team during the data collection; for the assistance in the assessment of the verbal 
autopsies by the physicians S.P. Gattu, F. Rosini, R.H. Medina Campos, and A.G.C. Boef; 
and for the assistance in the statistical methodology by Dr B.J.A. Mertens and Prof. H. 
Putter (Department of Medical Statistics, Leiden University Medical Center) and by Prof. 
F.J. Willekens (Netherlands Interdisciplinary Demographic Institute and Max Planck 
Institute for Demographic Research).
Funding
This research was supported by the Netherlands Foundation for Advancements of 
Tropical Research (WOTRO 93-467), the Netherlands Organization for Scientific 
Research (NOW 051-14-050), the EU funded Network of Excellence LifeSpan (FP6 
036894), an unrestricted grant of the Board of the Leiden University Medical Center, and 
Stichting Dioraphte. None of these organisations had any role in the design, analysis, 
interpretation or report of the study.
35
Determinants of the epidemiologic transition
REFERENCE LIST 
[1] Omran AR. The epidemiologic transition: a theory of the epidemiology op 
population change. Milbank Mem Fund Q 1971;49:509-38.
[2] Kahn K, Garenne ML, Collinson MA, Tollman SM. Mortality trends in a new South 
Africa: hard to make a fresh start. Scand J Public Health Suppl 2007;69:26-34.
[3] Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. 
Part I: general considerations, the epidemiologic transition, risk factors and impact 
of urbanization. Circulation 2001;104:2746-53.
[4] Rayco-Solon P, Moore SE, Fulford AJ, Prentice AM. Fifty year mortality trends in 
three rural African villages. Trop Med Int Health 2004;9:1151-60.
[5] Agyei-Mensah S, de-Graft Aikins A. Epidemiological transition and the double 
burden of disease in Accra, Ghana. J Urban Health 2010;87(5):879-97.
[6] Cohen B. The emerging fertility transition in sub-saharan Africa. World Dev 
1998;26:1431-61.
[7] Garenne M, Joseph V. The timing of the fertility transition in Sub-Saharan Africa. 
World Dev 2002;30:1835-43.
[8] Remais JV, Zeng G, Li G, Tian L, Engelgau MM. Convergence of non-communicable 
and infectious diseases in low- and middle-income countries. Int J Epidemiol 
2013;42:221-7.
[9] Van Bodegom D, May L, Kuningas M et al. Socio-economic status by rapid 
appraisal is highly correlated to mortality in rural Africa. Trans R Soc Trop Med Hyg 
2009;103:795-800.
[10] Kuningas M, May L, Tamm R et al. Selection for genetic variation inducing pro-
infammatory responses under adverse environmental conditions in a Ghanaian 
population. PLoS ONE 2009;4:e7795.
[11] Ghana Living Standards Survey: Report of the fifth round (GLSS 5). Ghana Statistical 
Service; 2008.
[12] Ghana Demographic and Health Survey 2003. Calverton, Maryland: Ghana 
Statistical Service, Noguchi Memorial Institute for Medical Research, and ORC 
Macro; 2004.
[13] Upper East Region Land Conservation and Smallholder Rehabilitation Project 
(LACOSREP): Phase II. Interim Evaluation. Report number 1757-GH. International 
Fund for Agricultural Development (IFAD); 2006.




[15] Ziem JB, Olsen A, Magnussen P et al. Distribution and clustering of 
Oesophagostonum bifurcum and hookworm infections in northern Ghana. 
Parasitol 2006;132:525-34.
[16] Koopman JJE, van Bodegom D, Jukema JW, Westendorp RGJ. Risk of cardiovascular 
disease in a rural African population with high infectious load: a population based 
study. PLoS ONE 2012;7:e46855.
[17] Boef AGC, May L, van Bodegom D et al. Parasitic infections and immune function: 
effect of helminth infections in a malaria endemic area. Immunobiol 2013;218:706-
11.
[18] Meij JJ, de Craen AJM, Agana J et al. Low-cost interventions accelerate epidemiologic 
transition in Upper East Ghana. Trans R Soc Trop Med Hyg 2009;103:173-8.
[19] WHO/UNICEF Joint Monitoring Programme (JMP) for Water Supply and 
Sanitation. Types of drinking-water sources and sanitation. http://www.wssinfo.
org/definitions-methods/watsan-categories/ [accessed 3 January 2014].
[20] Chandramohan D, Maude GH, Rodrigues LC, Hayes RJ. Verbal autopsies for adult 
deaths: their development and validation in a multi-center study. Trop Med Int 
Health 1998;3:436-46.
[21] Kahn K, Tollman SM, Garenne M, Gear JS. Validation and application of verbal 
autopsies in a rural area of South Africa. Trop Med Int Health 2000;5:824-31.
[22] Setel PW, Whiting DR, Hemed Y et al. Validity of verbal autopsy procedures for 
determining cause of death in Tanzania. Trop Med Int Health 2006;11:608-703.
[23] Soleman N, Chandramaohan D, Shivuya K. Verbal autopsy: current practices and 
challenges. Bull World Health Org 2006;84:239-45.
[24] Verbal autopsy standards: ascertaining and attributing cause of death. Geneva: 
World Health Organization; 2007.
[25] Van Bodegom D, Rozing MP, May L et al. Socio-economic status determines sex-
dependent survival of human offspring. Evol Med Public Health 2013;1:37-45.
[26] Borgerhoff Mulder M, Bowles S, Hertz T et al. Intergenerational wealth transmission 
and the dynamics of inequality in small-scale societies. Science 2009;326:682-8.
[27] Bowles S, Smith EA, Borgerhoff Mulder M. The emergence and persistence 
of inequality in premodern societies: introduction to the special section. Curr 
Anthropol 2010;51:7-17.
[28] Borgerhoff Mulder M et al. Pastoralism and wealth inequality: revisiting an old 
question. Curr Anthropol 2010;51:35-48.
[29] Shenk MK, Boergerhoff Mulder M, Beise J et al. Intergenerational wealth 
transmission among agriculturalists: foundations of agrarian inequality. Curr 
Anthropol 2010;51:65-83.
37
Determinants of the epidemiologic transition
[30] Beegle K, De Weerdt J, Dercon S. Migration and economic mobility in Tanzania: 
evidence from a tracking survey. Rev Econ Stat 2011;93:1010-33.
[31] Shier RP, Dollimore N, Ross DA et al. Drinking water sources, mortality and 
diarrhoea morbidity among young children in Northern Ghana. Trop Med Int 
Health 1996;1:334-41.
[32] Tiffen M. Transition in Sub-Saharan Africa: agriculture, urbanization and income 
growth. World Dev 2003;31:1343-66.
[33] Arevshatian L, Clements CJ, Lwanga SK et al. An evaluation of infant immunization 
in Africa: is a transformation in progress? Bull World Health Organ 2007;85:549-
457.
[34] Bawah AA, Phillips JF, Adjuik M et al. The impact of immunization on the association 
between poverty and child survival: evidence from Kassena- Nankana District of 
northern Ghana. Scand J Public Health 2010;38:95-103.
[35] Rutherford ME, Mulholland K, Hill PC. How access to health care relates to under-
five mortality in sub-Saharan Africa: systematic review. Trop Med Int Health 
2010;15:508-19.
[36] Blanchet NJ, Fink G, Osei-Akoto I. The effect of Ghana’s national health insurance 
scheme on health care utilisation. Ghana Med J 2012;46:76-84.
[37] Teo K, Chow CK, Vaz M et al. The Prospective Urban Rural Epidemiology (PURE) 
Study: examining the impact of societal influences on chronic noncommunicable 
diseases in low-, middle-, and high-income countries. Am Heart J 2009;158:1-7.
[38] Maher D, Sekajugo J. Research on health transition in Africa: time for action. Health 
Res Policy Syst 2011;9:5.

Chapter 3
SEASONAL VARIATION IN CHILD AND 
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Mortality in tropical countries varies considerably from season to season. As many of 
these countries have seen mortality moving from child mortality to old-age mortality, 
we have studied seasonal variation in child and old-age mortality in a rural area in 
Ghana that currently undergoes an epidemiologic transition. In an annual survey from 
2002 through 2011, we followed 29,642 individuals and obtained the cause and month 
of death from 1,406 deceased individuals by making use of verbal autopsies. When 
comparing the seasons, we observed a trend for higher mortality during the wet season. 
When comparing separate months, we observed 34% more deaths than expected in 
September (95% CI:1.04-1.69, p=0.024) at the end of the wet season and 43% more 
deaths in April (95% CI:1.13-1.80, p=0.004) at the end of the dry season, while there 
were 42% less deaths than expected in December (95% CI:0.52-0.70, p=0.003) shortly 
after the wet season. Cause-specific analysis indicated that the peak at the end of the wet 
season was due to excess mortality from infectious diseases in children and older people 
alike, whereas the peak in old-age mortality at the end of the dry season was due to 
non-infectious causes in older people only. Taken together, our data suggest that during 
the epidemiologic transition, mortality not only shifts from child to old-age and from 
infectious to non-infectious, but also from the wet to the dry season. 
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INTRODUCTION
Worldwide, there is variation in mortality depending on the season.[1-7] In tropical 
countries with a distinct dry and wet season, this is characterised mostly by excess 
mortality during the wet season.[8,9] Most studies analysing seasonal mortality have 
examined these patterns only for mother and child mortality.[10,11] It was found that 
excess mortality in the wet season is best explained by an increase in gastrointestinal 
infections and malaria.[8-11] 
Currently, many of these tropical countries are experiencing an epidemiologic transition, 
with mortality moving from child mortality to old-age mortality.[12-15] This is primarily 
due to improved living conditions and a lower risk to die from infectious diseases.[15-17] 
At the same time deaths from chronic diseases are on the rise.[14] It is yet unclear how 
the seasonal variation in mortality has evolved now that many of these countries have 
undergone major changes in their mortality patterns.
In this study, we have analysed seasonal patterns of mortality among children and 
older people from a unique population in rural Ghana, which currently experiences the 
epidemiologic transition. Additionally, we collected the causes of death using verbal 
autopsies. We first studied whether the dry and the wet season involved a proportional 
number of deaths and second, whether each month comprised an equal number of 




MATERIALS & METHODS 
Study area & population
The study is conducted in the Garu-Tempane district, which is situated in the Upper 
East region of Ghana. This region is far less developed than the southern part of Ghana 
and is highly endemic for malaria (85% of the population is infected with Plasmodium 
falciparum), typhoid fever, meningococcal disease and intestinal helminth infections.[18-
22] The research area is situated close to the village of Garu and measures approximately 
375 km2, with almost 30,000 individuals living in around 40 villages. The people in the 
research area live in polygamous extended families, with an average of 15 people per 
household. The families live together in compounds: clay structures with thatched roofs, 
connected by clay walls.[23,24] There are 1,719 compounds in the research area. Most 
people rely on traditional healers, which are equally distributed throughout the area. 
Although there are a few basic health care facilities (Community-based Health Planning 
and Services compounds) in the area, there is no medical doctor present, and the nearest 
hospital is 40 km away.[21] The vast majority of the population are farmers, and the total 
agricultural process is done by hand. The local economy is dominated by the Barter 
system, where goods are directly exchanged for other goods or services.[25,26] From 
around 1970 onwards, water boreholes that use hand operated pumps to deliver ground 
water, were introduced to the region. These boreholes were distributed throughout the 
area by a non governmental organisation, independent of the socioeconomic status of 
surrounding households. Drinking water source has been assessed at the household 
level in 2007. In spite of the boreholes, some of the villages still depend on rainwater 
and water from small streams that flow through the area. Water from boreholes has 
been found to contain less pathogens and is considered to be safe drinking water, water 
drawn from either open wells or from rivers was found to contain more pathogens and 
is therefore considered to be unsafe drinking water.[22]
Climate
The research area is characterized by a pronounced dry and wet season. The area is 
drier than southern areas of Ghana and is proximate to the Sahel and the Sahara. The 
dry season is influenced by the Harmattan, a dry and dusty desert wind that blows from 
the northeast. During this period the humidity is very low and rainfall is entirely absent, 
resulting in hot days and cool nights. The wet season is influenced by the tropical maritime 
air mass, which provides the area with rain.[27,28] Exact data of temperature and rainfall 
in the research area were available from a research project between 1991 and 2004.[23] 
(Ghana Government Data from the Garu Tempane district provided by Roger Blench) 
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Between 1991 and 2004, the daily mean temperature is 28.5 °C. The mean minimum 
monthly temperature is 25 °C, whereas the mean maximum monthly temperature is 32 
°C. From November to March, the minimal night temperature is 15 °C and the maximum 
day temperature 45 °C. The annual mean temperature was 28.9 °C and the annual amount 
of precipitation 996 mm.
Verbal autopsies
To obtain the causes and time of death, we used the validated verbal autopsy questionnaires 
from the World Health Organization (WHO).[29-31] In 2011 we performed the verbal 
autopsies in the area to identify the causes of death in both elderly and children. The 
WHO verbal autopsy method is based on a semi-structured questionnaire to conduct 
interviews with relatives or caretakers of deceased individuals. We have translated the 
English questionnaires into the two major local languages; Bimoba and Kusaal. To test 
whether the questionnaires were translated correctly, we performed back translations 
by an independent translator. In cases of discrepancy, the final translation was decided 
upon after group discussions with native speakers and medical experts. We trained local 
people from the two main tribes in the area to perform the interviews in people from their 
tribe in the field. They were instructed to search for the most appropriate respondent, 
which was in most cases a relative or caretaker of the deceased. The questionnaires 
were systematically checked by supervisors from the field staff who regularly participated 
during the field visits as well. From the total of 1,406 individuals that had died from 
2003 to 2011 and were registered in the database, we were able to complete 1,263 verbal 
autopsies (90%). From 10% we were not able to perform a verbal autopsy interview 
due to various reasons, such as absence at the time of the field visit, no appropriate 
respondent found or in a few cases refusal to participate. Informed consent was obtained 
by reading the consent statement from the verbal autopsy protocol of the World Health 
Organisation aloud in the local language.[29] Consent was documented by signature 
or thumbprint of the participant. The study was approved by the Ghana Health Service 
Ethical Review Committee. To assign the causes of death we used a physician review 
method. In the first round, two physicians assigned the causes of death independently, 
blinded for each other. The agreement of the first two physicians in assigning the causes 
of death was in line with other studies using verbal autopsies with an average kappa of 
0.41. If there was discrepancy between the first two diagnoses of the physicians, a third 
physician, who was not blinded for the diagnoses of the first two physicians, gave an 
independent assessment. A cause of death was determined if at least two of the medical 
doctors agreed, otherwise the cause of death was classified as unknown. To code the 
causes of death we used the International Classification of Diseases (ICD) VA-10 coding, 
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according to the WHO verbal autopsy method.[31] To study the seasonal variation in 
mortality we compiled the various causes of death into two categories: infectious diseases 
and non-infectious diseases. To test the repeatability of the verbal autopsy interviews, 
we performed re-interviews in a random selection of 10% of the original interviews. We 
tested the agreement between the diagnosis of the original interview and the re-interview 
and found an agreement with a kappa of 0.41. Since a proportion of the local population 
is not used to using dates and months, data on the exact month of death was not always 
available. Therefore, we additionally added a question about the season of death (dry or 
wet). 
Socioeconomic status
In 2007 we measured socioeconomic status at the household level using the 
Demographic and Health Survey (DHS) methods, specifically designed for our research 
area.[32] First we developed a questionnaire to assess the socioeconomic status of the 
study participants by using a listing technique whereby we asked people from different 
villages of the research area, in focus group discussions, to list the household items of 
most value. We than applied the method used to calculate the DHS-wealth index. For 
analysis, the results of this DHS-wealth index were split by the median in households 
with low socioeconomic status (poor) and households with high socioeconomic status 
(rich). For a detailed description of these methods we refer to an earlier publication of 
this study.[33]
Statistical Analysis
We used a Fishers exact test to assess whether the observed monthly mortality was 
significantly different than expected under the null-hypothesis that seasonal variation is 
absent.[34] We calculated the confidence intervals of the count data based on a Poisson 
distribution.[35,36] To test for agreement between physicians who assigned the causes of 
death, and the repeatability of the verbal autopsy interview, kappa values were calculated. 
All these analyses were carried out using SPSS 18 (SPSS Inc., Chicago, IL, USA). 
Additionally, we further analysed the data using STL: a seasonal-trend decomposition 
procedure based on Loess.[37] This is a filtering procedure for decomposing a time series 
into trend, seasonal and remainder components and was carried out in R. 
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RESULTS 
From 2002 through 2011 we followed 29,642 individuals for mortality in the Garu 
Tempane District of the Upper East Region of Ghana, as shown in Figure 1. 
Figure 1. Map of the research area in the Garu-Tempane District in the Upper East Region in 
Ghana.
The general characteristics of the study population are summarized in table 1. Most 
individuals lived in compounds with a high socioeconomic status (61%) and had access 
to safe drinking water (79%). The Bimoba tribe was most represented (66%), followed 
by Kusasi (26%). Other tribes, including Mamprusi and Fulani together made up to 8% 
of the deceased individuals. 
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Table 1. Characteristics of the study population from 2002 trough 2011. 




Total 29,642 (100%) 1,406 (100%)
Sex 
   Men 13,628 (46%) 786 (56%)
   Women 16,014 (54%) 620 (44%)
Socioeconomic status
   Poor 10,205 (35%) 580 (41%)
   Rich 18,414 (61%) 795 (57%)
   Unknown 1,025 (4%) 31 (2%)
Drinking water
   Unsafe 5,677 (19%) 308 (22%)
   Safe 23,428 (79%) 1,095 (78%)
   Unknown 537 (2%) 3 (0%)
Age
   Children (0-14) 12,613 (43%) 401 (29%)
   Adults (15-64) 15,369 (52%) 494 (35%)
   Elderly (65+) 1,660 (6%) 511 (36%)
Tribe
   Bimoba 19,451 (66%) 893 (64%)
   Kusasi 7,777 (26%) 418 (30%)
   Other/Unknown 2,415 (8%) 95 (7%)
During the period of follow-up we observed 1,406 deaths, of which 786 (56%) were 
men and 620 (44%) were women. Indicative for the on-going epidemiologic transition 
we observed a decline in the ratio of infectious- over non-infectious causes from 1.2 
to 0.7 over the nine years observation period (p for trend 0.014). From the total of 
1,406 deceased individuals, we were able to obtain the season of death for 1,061 (75%) 
individuals and for 627 (45%) we could additionally recollect the exact month of death. 
These three groups did not differ significantly in their baseline characteristics or recall 
period. 
The monthly variation in the average temperature and rainfall in the research area is 
presented in Figure 2. Temperature ranges from a mean of 26.8 °C in August to 32.4 
°C in March and April, whereas rainfall varies from a mean of 0.2 mm in January and 
December to a peak of 263.1 mm in August. The area has two distinct seasons, a dry 
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season that lasts for seven months from October to April and a wet season that lasts for 
five months from May to September.
Figure 2: Climatologic variation in the research area, indicated by the mean monthly temperature 
and mean monthly rainfall. The annual mean temperature was 28.9 °C and the annual amount of 
precipitation 996 mm. Source: Ghana Government, provided by Roger Blench.
We first analysed the observed number of deaths per month between the wet and the dry 
season (table 2). Overall there was a trend for higher mortality during the wet season. 
When stratifying for socioeconomic status, we observed higher mortality during the wet 
season in both rich and poor households. Finally, we observed that only people who 
made use of safe drinking water had lower mortality during the wet season.
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Table 2. Number of deaths per month in wet and dry season for various subgroups.
Wet season Dry season
Number of deaths 
per month
(95% CI) Number of deaths 
per month
(95% CI)
All deaths 95 (77-116) 84 (67-101)
Age
   Child (0-14 years) 26 (17-38) 21 (14-33)
   Adult (15-64 years) 33 (23-46) 30 (20-43)
   Old-age (65+ years) 36 (25-50) 32 (22-45)
Socioeconomic status
   Poor 38 (27-52) 33 (23-46)
   Rich 56 (42-73) 49 (36-65)
Drinking water
   Unsafe 26 (17-38) 18 (11-29)
   Safe 59 (45-76) 66 (51-84)
* The number of deaths per month were calculated by dividing the observed number of deaths in 
a season by the number of months in that season. CI = confidence interval.
Next, we examined the longitudinal data series in a seasonal-trend decomposition 
procedure. We decomposed the mortality data in a seasonal component, a secular trend 
and remaining variation, as shown in Figure 3. The model identified mortality peaks 
in April and September and low mortality in December. When comparing the separate 
months, we observed 34% more deaths than expected in September (95% CI: 1.04-1.69, 
p=0.024) at the end of the wet season and 43% more deaths in April (95% CI: 1.13-1.80, 
p=0.004) at the end of the dry season, while there were 42% less deaths than expected 
in December (95% CI: 0.52-0.70, p=0.003) shortly after the wet season. This seasonal 
variation overlapped for 44% with the data, while the secular mortality trend overlapped 
with 51% of the data. Comparing the seasonal trends over calendar time, the mortality 
peak in April was most pronounced in recent years (data not shown). 
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Figure 3. The seasonal variation in mortality over the months from 2003 through 2011. This filtering 
procedure decomposes the raw data into a seasonal component, a trend and remaining variation.
To further explore the causes of the seasonal variation, we stratified for child and old-
age mortality. Figure 4 illustrates that child mortality shows one mortality peak during 
the wet season in September with 74% (95% CI: 1.09-2.63, p=0.021) more deaths than 
expected, whereas there was 69% less lower than expected in January (95% CI: 0.08-
0.78, p=0.007). In contrast, old-age mortality shows two mortality peaks: in September 
there were 54% (95% CI: 1.06-2.18, p=0.025) more deaths than expected and in April 
there were 40% (95% CI: 1.06-2.18, p=0.098) more deaths than expected. In December 
there were 39% less deaths than expected (95% CI: 0.32-1.04, p=0.073). 
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Figure 4. Seasonal variation in child mortality and old-age mortality. Mortality is expressed as 
number of deaths per month with error bars indicating 95% confidence interval. Stars indicate 
whether the observed number of deaths in that month are significantly higher than expected. 
*p<0.1, ** p<0.05
Figure 5 shows the seasonal variation in the number of deaths due to infectious- and 
non-infectious causes. Among children (panel A), 68% of the deaths were due to 
infectious diseases and appeared 75% (95% CI: 1.42-2.19, p=0.057) higher in September 
at the end of the wet season. In January there was 66 % (95% CI: 0.19-0.59, p=0.048) 
mortality from infectious diseases. Mortality from non-infectious causes appeared to 
be equally distributed over the months. Among older people (panel B), infectious and 
non-infectious causes of death were equally common. Mortality from infectious causes 
in old age peaked in September with 74 % (95% CI: 0.97-2.87, p=0.061) higher mortality, 
whereas mortality from non-infectious causes peaked with 52% higher mortality in both 
September and April, (95% CI: 0.87-2.47, p=0.0138).
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Figure 5. Seasonal variation in mortality from infectious and other causes in child mortality (panel 
A) and old-age mortality (panel B). Mortality is expressed as number of deaths per month with 
error bars indicating 95% confidence interval. Stars indicate whether the observed number of 




In a rural area in Ghana, we have observed a mortality peak in the wet season for both 
child and old-age mortality that can be explained by an increased number of deaths from 
infections. There was however, a second mortality peak at the end of the dry season 
among older people due to non-infectious causes. There was low mortality in the months 
succeeding the wet season.
Variation in mortality is both, driven by geographical factors such as climatic influences 
and by individual or household determinants.[38] Therefore, we additionally studied the 
role of socioeconomic status and the use of (un)safe drinking water. Mortality during 
the wet season was higher for people from both rich and poor households. Although 
the effect size was similar for both groups, it was only significant in the (larger) group 
of the rich. By contrast, water source did influence the seasonal variation in mortality 
as indicated by the higher mortality during the wet season in individuals using unsafe 
drinking water. It is tempting to speculate that the observed excess mortality during 
the wet season in people drinking unsafe water could be explained by contamination of 
drinking water during the wet season, when unsafe open wells are flooded with surface 
water. 
Climate could influence mortality via its effects on agriculture and disease transmission. 
Overall, it has been found that sub-Saharan African countries with long lasting rainy 
seasons have lower mortality rates when compared to countries that have shorter wet 
seasons. Most likely this is due to the fact that longer wet seasons foster agriculture and 
hence food abundance.[38] In line with this interpretation we observed low mortality 
for all age groups in December and January, directly following the wet season. The 
increased mortality during the wet season has been mostly explained by an increase in 
gastrointestinal infections and malaria during that season.[8,9,39,40] Our findings in the 
research area are in line with these data. Prior examination of our group has indicated 
that guinea worm, schistosomiasis and malaria have a high prevalence at the end of the 
wet season and the transmission of malaria is highest at that time.[18,39] Compared to 
the dry season, the wet season shows increased parasitemia and severe anaemia rates 
in children.[41] Since children and older people are most susceptible to malaria, these 
factors possibly contribute to the excess mortality at the end of the wet season that we 
have observed.[40] Also, the incidence of gastrointestinal infections, skin infection and 
snake bites are higher during the wet season.[40]
53
Seasonal variation in mortality 
The mortality peak during the wet season in September was driven by infectious diseases 
and affected children and older people alike. By contrast, mortality among older people 
showed a second peak during the dry season in April, due to non-infectious causes. The 
excess mortality for elderly could be partly explained by the harsh conditions at the end 
of this season, when food is limited and expensive, as reflected in the prices of crop 
and livestock.[23] This is however, not reflected in a higher mortality among children. 
Perhaps more important for older people, average temperature is highest at the end of 
the dry season in March and April. This will mostly affect older people with underlying 
cardiovascular diseases, that are especially prone for heat-associated mortality. During 
the epidemiologic transition in the area, infectious deceases are decreasing together 
with an increase in the prevalence of chronic diseases, and this could well be reflected 
by a change in patterns of seasonal variation in mortality. Hence, the peak in September 
is most likely to decrease, whereas mortality among older people at the end of the dry 
season in April will probably increase in the future. This reasoning is supported by the 
observation that the peak in April was more prominent in recent years. 
The clustering of mortality over calendar time is in line with earlier findings in the research 
area, where we have described significant clustering of mortality, dependent on family 
and household characteristics, such as socioeconomic status.[42-45] Next to clustering 
on a geographical and family level we now show that mortality is clustering in time also. 
We believe that studying whether mortality is seasonal and in what months we can expect 
excess mortality are relevant research questions, especially in such a rural environment 
with high infection pressure. Further insights in the seasonal variation in mortality in 
rural Ghana can be a first step towards better prevention and public health. We believe 
we have shown both, that mortality is seasonal and the effect size, or amount of excess 
mortality in specific months. 
Several strengths and weaknesses of this study should be discussed. In a developing 
country with no available municipal registries, our longitudinal data set is a unique 
opportunity to study such a remote rural population. The verbal autopsy method is 
commonly used to assign causes of death in developing countries.[46,47] A limitation 
of our study is that we performed the verbal autopsy interviews in 2011 with a maximum 
recall period of eight years. Large variations in recall period could influence the data 
and it has hence been recommended that verbal autopsies should be performed only 
within two years after the deaths occurred.[48] However, in our data, the proportion 
of unspecified causes of deaths was not dependent on the recall period. This could be 
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partly explained by the fact that we only distinguished within the broader categories of 
infectious versus non-infectious causes of death. An additional explanation could be 
that since the majority of the people in the study area are farmers and the seasons are 
clearly linked to distinct agricultural activities, most do not have difficulty to recall the 
season of death. There was a moderate level of agreement between the adjudicating 
physicians, and between the original interviews and the re-interviews, which we have 
considered acceptable given the nature of verbal autopsies. A further limitation is that 
we lack precise data on fertility and migration rates. If fertility would have a seasonal 
pattern, this could be reflected in the variation in mortality as well. Migration will have 
especially influenced our results in young adults, as at this age individuals are most likely 
to move in and out of the area. It is less plausible that this has influenced child and old-
age mortality. 
All in all, this study shows that during the epidemiologic transition in tropical countries, 
mortality not only shifts from child mortality to old-age mortality, and from infectious 
to non-infectious causes of death, but that the distribution of deaths over the seasons 
probably changes as well. A better understanding of seasonal variation in mortality is of 
prime importance for public health policies.  
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LIMITS TO THE COMPRESSION 
OF HUMAN MORTALITY 





Experimental data suggest a limit to the compression of mortality based on the stochastic 
element in the ageing process. There is on-going debate whether in future mortality will 
be further compressed in humans. Here we have studied compression of mortality not 
only in relation to calendar time, but also, in relation to life expectancy to further elucidate 
the underlying process. We obtained life tables from Japan and the Netherlands, two 
countries that showed different trends in life expectancy from 1947 through 2008. As 
an indicator of mortality compression, we used the shortest age interval in which fifty 
percent of the annual mortality occurred (C50). In Japan and the Netherlands the C50 
followed similar trajectories, only on a different time scale. We observed a limit to the 
compression of mortality in which fifty percent of annual mortality was compressed within 
an age band of 12 years in both countries, while life expectancy considerably improved. In 
accordance with genetic experimental data and in line with current theory on ageing, the 
observed limit to the compression of mortality is most probable determined by a residual 




In countries that have undergone so-called demographic transition, mortality has shifted 
from younger to older ages, and the distribution of age-at-death has been compressed into 
a narrower interval, sometimes described as “rectangularization of the survival curve”.
[1,2] In a classic paper Fries (1980) was the first to define the concept of ‘compression’ 
of mortality and age-related morbidity, based on assuming a predetermined (and fixed) 
age-at-death. In other words, as individuals tended to live longer, deaths would become 
ever more crowded into a progressively later interval before the species-specific, fixed 
age-at-death.[3] However, Fries’ assumptions have been overturned by subsequent 
progress in both demography and biology, providing fresh impetus for asking what is 
happening with respect to compression of morbidity.[4] Demographic observations 
indicate continuous increase in both average lifespan and the maximum age-at-death, 
whereas modern theory on ageing does not support a predetermined or fixed lifespan.
[5] Instead, ageing is considered as an un-programmed process due to a stochastic 
accumulation of damage over time, the speed of which is dependent on both genetic 
and environmental determinants.[6,7] In this scenario, it is the accumulation of damage 
leading to the dysfunction of tissues and organs that explains the incremental risk of 
disease and disability, up to the moment that the amount of damage reaches a threshold 
that is no longer compatible with life.[8,9] Inherent to such damage accumulation, there 
will always be an individual variation in this stochastic process and therefore, the limit 
to the compression of old-age mortality will always be above zero. Moreover, this is in 
line with results from a classic genetic experiment in Caenorhabditis elegans, where the 
age-at-death distributions of a wilt-type population and an age-1 mutant population with 
an increased life span, were compared. In this experiment, the dispersion of mortality 
in the age-1 mutant population expanded, but this was proportional to the increase in 
lifespan.[10]
The continuing debate about whether the human age-at-death distribution will be further 
compressed as the modal age-at-death increases is of fundamental as well as societal 
interest. In part, the situations remains unclear because various indicators have been 
used with contradictory results.[1,11-17] The standard deviation above the modal age-
at-death (SD M+) is the most often used indicator of mortality compression, but it 
estimates compression of mortality above the modal age-at-death only, and thus merely 
in the oldest old. Out of the different indicators of mortality compression, Kannisto 
(2000) favoured C50, the shortest age-interval in which half of the annual mortality 
occurred, as the best, since it captures mortality compression on both sides of the modal 
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age-at-death.[16] A further limitation of previous studies on mortality compression was 
that they investigated compression of mortality over calendar time only.[1,11-17] Both life 
expectancy and mortality compression vary with annual fluctuations in the environment 
such as epidemics (especially influenza), economic and climatic changes. Hence, the 
study of mortality compression is incomplete when it is not related to the development 
of life expectancy.  
Here, we studied the compression of the age-at-death distribution in Japan and the 
Netherlands, two countries with very different trajectories. Worldwide, life expectancy was 
highest in the Netherlands during the 1950’s and 1960’s. At the same time life expectancy 
in Japan was lagging far behind when compared to the Netherlands, but life expectancy in 
Japan subsequently showed an accelerated increase and then surpassed life expectancy 
in the Netherlands from the early eighties onwards. By comparing the mortality patterns 
in Japan and the Netherlands, we are able to disentangle the influences of calendar time 
and life expectancy on the compression of mortality. This provides further insight into 
the intrinsic process of mortality compression with important implications for future 
demographic and healthcare scenarios.
MATERIALS & METHODS 
Data from Japan and the Netherlands were derived from the Human Mortality Database 
(HMD).[18] We used age-specific period mortality data from 1947 to 2008, with an age 
and year interval of 1x1. 
To study the compression of mortality, we first calculated the modal age-at-
death (M) according to Kannisto.[17] The age-specific deaths (d(x)) in the Human 
Mortality Database are recorded on an annual basis, and hence d(x) is given by 
the full year. However, since deaths are not equally distributed within a year, we 
have to calculate a more precise estimate according to the following formula: 
  
 
Where M is the modal age-at-death, x is the age with the highest d(x) in late life and d(x) 
is the number of deaths between age x and x + 1. 
We next calculated the shortest age interval in which fifty percent of the annual mortality 
occurred in a specific year (C50) as an indicator of the compression of mortality, according 
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We next calculated the shortest age interval in which fifty percent of the annual mortality 
occurred in a specific year (C50) as an indicator of the compression of mortality, according to 
Kannisto. We used a total cohort of 100,000 and sorted the life table data by the d(x) in 
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to Kannisto. We used a total cohort of 100,000 and sorted the life table data by the 
d(x) in descending order and summed the d(x) values, starting with the highest value, 
until the total first exceeded 50,000. The number of years it takes to reach the total of 
50,000 equals the shortest age interval in which fifty percent of mortality occurred in that 
year. Since we were interested in the compression of old-age mortality we only studied 
mortality compression above age 20, in order to exclude infant and child mortality. We 
hence summed up the d(x) values above age 20. As described earlier, d(x) is recorded 
in full years. Therefore, we first calculated the number of ages needed to reach a total 
of 50,000 after which we subtracted the fraction of the last added year that exceeds 
the specified total, in order to get a better estimate. A more detailed description of this 
method can be found in the publication by Kannisto.[16] To examine the trends of the 
C50 indicator over life expectancy, we calculated the C50 indicator for the years in which 
life expectancy was closest to 50, 55, 60, and so on. 
In addition to the human data, we studied the compression of mortality in worm 
populations of Caenorhabditis elegans using data re-plotted by Kirkwood and Finch (2002) 
from an original experiment by Johnson (1990).[10,19] For these data we additionally 
calculated the relative C50, which is the C50 devised by the mean age-at-death.
RESULTS 
Figure 1 shows the age-at-death distribution for Japanese and Dutch women from 1950 
to 2008. In Japan after 1950, the initial decrease in early mortality was followed by a 
decrease in mortality at older ages, concomitant with a compression of the age-at-death 
distribution and a shift to increasingly higher ages. From 1950 to 2008, the modal 
age-at-death increased from age 75.1 in 1950 to 92.2 in 2008. Compared to Japan, the 
Netherlands in 1950 showed almost no early mortality and mortality at old age that was 
already compressed to a narrow age-interval. Between 1950 and 2008 in the Netherlands, 
the modal age-at-death increased from age 78.3 to 89.1. 
We calculated C50 as an indicator of mortality compression. Figure 2 shows the C50 
values for Japanese and Dutch women over calendar time from 1947 to 2008. In 1947, 
the C50 for women was 25.8 years in Japan and decreased to 12.0 years in 2008. In the 
Netherlands the C50 started at a lower level of 15.6 years and by 2008 it had decreased 
to 12.3 years for women. Apparently, the C50 approached a limit, in which fifty percent 
of annual mortality occurred within an age band of 12 years in both countries. In the 
Netherlands, this limit remained stable over the last fifty years. 
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Figure 1. The annual age-at-death distribution of women in Japan and the Netherlands from 1950 to 




Figure 2. The compression of mortality, estimated by the shortest age interval in which fifty percent 
of the annual mortality occurred (C50), in relation to calendar time from 1947 to 2008.
Between 1947 and 2008 life expectancy of women increased from 53.7 to 86.0 years in 
Japan. For the Dutch, the corresponding life expectancy increased less, from 70.8 to 82.3 
years. Since life expectancy for women in the Netherlands was already 70.8 years in 1947, 
we additionally calculated the C50 indicator for the Dutch women in earlier years, when 
life expectancy of the Dutch was similar to that of Japan in 1947. In the years 1896, 1907, 
1922 and 1931 Dutch life expectancy first reached 50, 55, 60 and 65 years respectively. In 
figure 3 these additional estimates complete the historical development the C50 indicator 
over life expectancy in the Netherlands, and this shows that it practically overlaps with 
the trajectory of Japan. 
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Figure 3. The compression of mortality, estimated by the shortest age interval in which fifty percent 
of the annual mortality occurred (C50 ), in relation to life expectancy in women of Japan and the 
Netherlands. For the Netherlands additional estimates are presented for the years 1896, 1907, 
1922 and 1931, the years in which Dutch female life expectancy first reached 50, 55, 60 and 65 
respectively.
In table 1 the C50 indicator is additionally summarized for men. In men the trends in 
mortality compression were alike when compared to women. The trajectories of C50 
over calendar time are different between the two countries. However, when studying the 




Table 1. The shortest age interval in which fifty percent of the annual mortality occurs (C50) as an 
indicator of mortality compression, over calendar time and life expectancy for women and men in 
Japan and the Netherlands. 
 Women C50 (years) Men C50 (years)
Japan Netherlands Japan Netherlands
Calendar time
     1950 20.9 14.4 21.7 15.7
     1960 15.3 13.4 16.9 15.9
     1970 13.7 13.6 15.6 16.9
     1980 12.5 13.5 14.7 16.1
     1990 11.9 13.0 14.5 15.1
     2000 12.3 12.7 15.1 14.2
     2008 12.0 12.3 14.9 13.6
Life expectancy
     50 25.8 28.2 27.6 28.9
     55 23.5 23.9 25.1 22.8
     60 20.9 19.6 20.6 19.6
     65 17.7 18.4 17.4 17.2
     70 15.3 15.6 15.6 16.5
     75 13.7 13.4 14.6 15.5
     80 12.3 13.4 14.9 14.7
In addition to the data for humans, we also examined distributions of individual life 
spans for two populations of the nematode Caenorhabditis elegans, one of wild-type and 
one carrying the life-extending age-1 mutation. Table 2 shows the values of C50 and 
mean life span for each population as well as the equivalent values for Japan and the 
Netherlands in 1950 and 2008. Although there is a difference in mean life span between 
the two worm genotypes, and a corresponding increase in C50, the relative C50 values 
(C50/mean age-at-death) for the two genotypes are similar. The absolute and relative 
C50 in Japan and the Netherlands decrease over time. In both countries, the C50 values 
reaching similar levels in 2008.
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Table 2. Values of C50, mean and relative C50 (C50/mean age-at-death) for two genotypes of the 
nematode Caenorhabditis elegans and for human population in Japan and the Netherlands in 1950 
and 2008.
Mean age-at-death C50 Relative C50
Worm population days days
   Wild type 20.81 3.96 0.19
   Age-1 mutant 36.27 6.99 0.19
Human population
   Japan years years
      1950 67.75 20.85 0.30
      2008 85.73 12.15 0.14
   The Netherlands years years
      1950 74.65 14.43 0.19
      2008 82.26 12.27 0.15
DISCUSSION
We have found that the compression of the age-at-death distribution in Japan and the 
Netherlands followed identical patterns in relation to life expectancy. In both countries, 
the compression of mortality approached a limit with an age band of 12 years when life 
expectancy at birth was 80 years and over. This may indicate a future shift of the age-
at-death distribution towards older ages without further compression. The analysis of 
compression of mortality in relation to calendar time yielded very different trajectories 
between the countries and was critically dependent on socioeconomic development.
It is still uncertain what factors determine this limit of compression. With the 
epidemiologic transition completed, the main causes of death have changed to ageing-
related diseases.[20,21] Hence the present compression of mortality should be interpreted 
within a theoretical framework of ageing, where it is now generally accepted that the 
ageing process is not programmed, but rather the result of a stochastic accumulation of 
damage over time.[6,7,22-24] As the accumulation of damage has a stochastic element, 
there inherently always will be an inter-individual variation in the age at which the amount 
of damage reaches the threshold that is no longer compatible with life and it is this 
residual variation in the rate of ageing that is most likely behind the observed limit of 
old-age mortality compression. 
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It might be argued that a more genetically homogeneous population could explain for 
the observed compression of mortality, but it is unlikely that variation in the population 
genome in Japan and the Netherlands has significantly changed during the observation 
period. Moreover, even in a homogeneous population there is residual variation in the 
age-at-death distribution, as illustrated by data for the nematode worm Caenorhabditis 
elegans. Worm populations grown in laboratories have exceptional genetic uniformity 
and are cultured under highly uniform conditions, yet they show extensive variation 
in age-at-death of individual worms.[10] The increase in lifespan in the age-1 worms is 
usually interpreted as being the result of a slowing of the intrinsic ageing process, which 
means in turn that the intervals between the individual stochastic events that contributes 
to ageing become proportionately longer. It is this effect that most plausibly explains 
the increase in absolute C50 value, but the constancy in relative C50. For humans, we 
do not think there has been any underlying change in the speed of the ageing process 
(although this cannot be completely excluded as a minor contributor) so the gains in 
mean lifespan that have been made, combined with the reduction in C50 are likely to 
reflect postponement of some of the stochastic events from earlier to later ages within 
a relatively unchanged overall lifespan. Such an interpretation would be consistent with 
the idea that the age-associated stochastic events are partly from internal biochemical 
events and partly driven by environmental and/or lifestyle factors: the external events are 
postponed by the changes associated with demographic transition, while the internal 
changes are relatively less affected, although it must be acknowledged that such a 
distinction, in the absence of relevant data, remains hard to confirm.[7]
It remains to be elucidated whether, for humans, a homogeneous environment could 
further compress the age-at-death distribution. Smoking history for instance, highly 
increases mortality risks of individuals, and a high smoking prevalence can even cause 
a stagnation in life expectancy, as has been observed in the Netherlands.[25,26] Other 
environmental disparity exists in socioeconomic status, which is also known to be a 
strong determinant of mortality.[27] Within the Netherlands, one of the more egalitarian 
countries of the world, there is a seven year difference in life-expectancy between the 
poorest and the richest socioeconomic strata.[28] Closely related to socioeconomic 
status is the level of education. Higher levels of education are associated with stronger 
compression of mortality.[29] In both countries, the proportion of people with higher 
education has increased during the studied period.[30,31] It is likely that increased levels 
of education could have, in part, contributed to patterns of mortality compression that 
we have found. It cannot explain however, that the age interval in which fifty percent of 
the annual deaths occurs, has remained stable in the Netherlands for almost fifty years. 
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Furthermore, it has being argued that better prevention and improved (access to) health 
care are behind the prior observed mortality compression. In Japan a universal health 
insurance was introduced in 1961 and could have contributed to the compression of 
mortality in Japan.[32] If in former time only a small part of the population had easy 
access to health care, the introduction of a universal health insurance will have left the 
Japanese population more equal in terms of accessibility to health care, resulting in a 
compression of mortality over the last decades. In the Netherlands a sharp rise in life 
expectancy was observed in 2002, which has been attributed to improvements in health 
care for elderly, however, this has not further compressed the age-at-death distribution in 
the Netherlands[33] Overall, a uniform environment in terms of life-style, socioeconomic 
status, access to healthcare or other factors, is able to postpone morbidity and mortality 
to higher ages and hence increase the mean age-at-death, however it is unlikely that it will 
further compress the age-at-death distribution at old age, due to the stochastic nature 
of ageing. 
It is a tempting idea that the compression of mortality that we have described, may 
also point to compression of morbidity. This should, however, be formally evaluated 
since the alternative scenario of decompression of morbidity is equally likely.[34,35] The 
explanation is that (fatal) complications of disease are prevented more effectively than 
the occurrence of disease per se.[35] Affluent lifestyles have resulted in an increasing 
burden of morbidity due to several chronic diseases, such as diabetes, atherosclerosis, 
cardiovascular disease and cancer, that more and more have become chronic diseases 
than a rapidly fatal disorders.[21] Further research on the evolution of patterns of 
morbidity is urgently needed to gain a full understanding of the implications of the 
changing mortality distributions for population health.
In conclusion, our observations in Japan and the Netherlands show a continuing shift 
of mortality to higher ages, together with a compression of the age-at-death distribution 
that appears to have reached a limit. This is in line with the current theory on ageing 
which is determined by a stochastic and uneven accumulation of damage over time, the 
speed of which determines the rate of ageing. It is the stochastic element in the process 
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SEX DIFFERENCES IN HEALTHY LIFE 
EXPECTANCY IN THE NETHERLANDS 
F.M. Engelaer, D. van Bodegom and R.G.J. Westendorp




For a long time, life expectancy at birth was used as the sole indicator of population 
health. More recently, population health is also being expressed as healthy life expectancy 
and it is debated how healthy life expectancy will develop in the future. Since it is known 
that men and women have very different health and disease trajectories, we compared 
healthy life expectancy between the sexes, at birth and at age 80. From 1985 to 2010 
life expectancy at birth in the Netherlands increased from 73.1 to 78.8 for men and 
from 79.7 to 82.7 for women. During the same period, the expected number of years 
without disabilities and in good self-reported health increased parallel, pointing to a 
shift of disability towards older age. Paradoxically, however, there has been an expansion 
of morbidity per se, as indicated by a continuing decrease in life expectancy without 
chronic diseases from 51.4 to 47.2 for men and from 48.8 to 40.6 for women. After these 
diverging trends of the last thirty years, Dutch women nowadays have a life expectancy 
that is 3.9 years longer than men but a life expectancy without chronic diseases that is 
6.6 years lower. When examining these figures in the oldest old, the number of years 
expected to live in good health is similar for the sexes, but women of 80 years can expect 
to live another 9.7 years, still almost two years longer than the 7.9 years for men. All in all, 
the increase of life expectancy in the Netherlands is accompanied by a shift of disability 
but an expansion of morbidity, which is much more pronounced in women. It remains to 
be examined what biological or social mechanisms are behind these large sex differences 
in healthy life expectancy in the Netherlands. 
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INTRODUCTION
In the last century, industrialized countries have gone through a demographic transition 
and showed a sharp increase in life expectancy at birth.[1,2] A major question is whether 
the additional years are spend in good health or in ill health. In the past decennia, it 
has therefore become practice to measure healthy life expectancy, which has been first 
introduced by Sullivan in the seventies.[3] Since the introduction there has been debate 
about how healthy life expectancy will develop in the future.[4-7] In this respect, it is 
important that men and women experience health and disease differently.[8,9] Healthy 
life expectancy trajectories, therefore, should be studied in the sexes separately. 
Three general theories on the future of healthy life expectancy have been proposed. 
Gruenberg was the first who described the expansion of morbidity theory, where 
the increase in life expectancy would be accompanied with a decrease in healthy life 
expectancy due to a growing prevalence of chronic diseases.[10] Others later supported 
this sobering view, in which life expectancy, on the long term, would reach a plateau.
[11-13] By contrast, Fries proposed the compression of morbidity, a more optimistic view 
proposing that diseases would be postponed to later in life, followed by a more or less 
sudden death.[14] In this scenario it was stated that with an increase in life expectancy, 
healthy life expectancy improves as well, at the end approaching life expectancy at birth. 
This was later supported by others who showed that an increase in life expectancy was 
not associated with a decrease in healthy life expectancy.[15] The third theory concerns 
the dynamic equilibrium status, where an increase in life expectancy would be combined 
with an expansion of mild disability, but also, with a decrease in severe disability and 
morbidity.[16] Several variants to these three main scenario’s have been proposed.[17-
19] It is still debated what scenario future life expectancy and healthy life expectancy will 
follow now that populations are ageing all over the globe.[20-22] 
We studied the trajectories of healthy life expectancy in men and women from 1985 to 
2010 in the Netherlands. We examined whether healthy life expectancy followed life 
expectancy at birth or whether the gap between the two further widened. 
We compared the trajectories for the two sexes and, in addition, we studied how these 
trajectories have evolved in the oldest old. Further understanding of these trajectories 




MATERIALS & METHODS 
Although there is consensus on how to calculate life expectancy at birth, there are 
many different ways to measure healthy life expectancy. The Dutch Centre for Statistics 
(CBS) uses three categories to measure healthy life expectancy: life expectancy without 
disabilities, life expectancy in good self-reported health, and life expectancy without 
chronic diseases.[23]
To establish the life expectancy without disabilities individuals aged 12 or above were 
questioned whether they were able to hear, see and move. Four categories were possible 
as an outcome on previous question: yes, with no trouble; yes, with some trouble; yes, 
with a lot of trouble; or no, not at all. Individuals responding with minimal one question: 
no, not at all; yes, with a lot of trouble; and yes, with some trouble were considered to have 
disabilities, either mild or severe. For the life expectancy in good self-reported health the 
following question has been asked: ‘How is your health in general’? Responders answering 
with good or very good were considered to be in good self-reported health. Finally, for the 
life expectancy without chronic diseases a specific group of chronic diseases has been 
selected, from which it is known that they severely influence mortality or the quality of 
life. This selection contains: asthma/COPD, cardiovascular disease, CVA, hypertension, 
gastro-intestinal disorders, diabetes, backache, rheumatic disorders/ joint problems, 
migraine and cancer. Individuals having none of above listed diseases in the last 12 months 
were considered to have no chronic diseases. Questions concerning cardiovascular 
disease, CVA, hypertension and joint problems were only asked to individuals aged 12 
years and over, with the assumption that those diseases do not occur below the age of 12. 
We have included period data on life expectancy at birth and life expectancy at age 80 




First, we compared the traditional trajectories of life expectancy at birth in relation to 
the trajectories of healthy life expectancy in the Netherlands. The latter was divided into 
three categories: life expectancy without disabilities, life expectancy in good self-reported 
health, and life expectancy without chronic diseases. Figure 1 shows all four trajectories 
from 1985 to 2010, for both men and women. 
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Figure 1. Trajectories of (healthy) life expectancy at birth from 1985-2010 in the Netherlands, for 
both men and women.
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For men, life expectancy at birth increased by 5.7 years, from 73.1 to a total of 78.8 years 
in 2010. In addition, the three categories of healthy life expectancy developed in different 
ways. Life expectancy without disabilities and life expectancy in good self-reported 
health, both developed parallel to the life expectancy at birth and increased 4.5 years 
from 65.7 to 70.2 years and 4.1 years from 59.8 to 63.9 years respectively. By contrast, life 
expectancy without chronic diseases decreased during the studied time period. In 1985, 
life expectancy without chronic diseases in men was 51.4 years. By 2010 it had decreased 
4.2 years to 47.6 years. 
For women, total life expectancy at birth increased by 3.0 years from 79.7 to 82.7 years. 
Life expectancy without disabilities increased 3.9 years from 65.8 to 69.7 years. Life 
expectancy in good self-reported health increased 0.1 year from 62.9 to 63.0 years. In 
accordance with the observations in men, life expectancy without chronic diseases 
decreased, 8.2 years from 48.8 to 40.6 years. In 1985, women had a higher total life 
expectancy at birth, but their healthy life expectancy was similar to men. However, 
during the studied time period, men and women followed very different trajectories of 
life expectancy without chronic diseases. While for both sexes life expectancy without 
chronic diseases decreased, there was a much larger decrease in women compared to 
men, leading to women living 6.6 years shorter without chronic diseases compared to 
men. 
In addition, we studied the trajectories of healthy life expectancy at age 80, shown in 
figure 2. For men, total life expectancy at age 80 and life expectancy without disabilities 
increased, respectively with 1.4 years from 6.5 to 7.9 years and 1.2 years from 3.0 to 4.2. 
There was only a marginal decrease in life expectancy in good self- reported health, which 
was 4.5 years in 1985 and 4.3 years in 2010. Life expectancy without chronic diseases 
decreased 0.3 years, from 1.6 to 1.3. For women, total life expectancy and life expectancy 
without disabilities, both increased; by 1.2 years from 8.5 to 9.7 years and 1.4 years from 
3.0 to 4.4 years respectively. Life expectancy in good self-reported health and without 
chronic diseases decreased with 1.4 years from 5.6 to 4.2 years and 2.2 years from 3.8 to 
1.6 years respectively. At age 80, women have a 2-year higher life expectancy, but they can 
expect to live the same number of years in good health, compared to men. 
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Figure 2. Trajectories of (healthy) life expectancy at age 80 from 1985-2010 in the Netherlands, for 




In the past decennia, the increase in life expectancy for both men and women in the 
Netherlands resulted in more years in good self-reported health and more years without 
disabilities. At the same time, an increasing number of years are lived with chronic 
diseases, indicating an expansion of morbidity. This last trend is observed in both sexes 
but is much more pronounced in women. There are two major explanations for this. 
First, it could be due to earlier diagnosis of diseases. Second, the prevalence of chronic 
disease, such as, cardiovascular disease and diabetes increased in the Dutch population 
during the studied time period.[24-26] This could also reflect changes in life style in this 
period. The extra years lived with chronic diseases (expansion of morbidity) however, do 
not necessarily suggest that we are becoming less healthy, since total life expectancy and 
disability free life expectancy increased. This suggests that early diagnosis and treatment 
postpone disabilities and increase our life expectancy. Several studies have also shown 
a relationship between the presence of chronic diseases during late adulthood and the 
manifestation of disabilities at older ages.[28-30] 
Others have proposed a trade-off between increasing life expectancy and worsening 
population health.[11] The Dutch trajectories on healthy life expectancy at birth and in 
the oldest old, however, do not support this theory. Even at old age, the increase in 
life expectancy is not accompanied by an increase of disability. In accordance to other 
findings, life expectancy at old age temporally stagnated during the nineties in the 
Netherlands.[31] In 2002 this was followed by a sharp increase in life expectancy at old 
age, which is also present in our data.[32] Our results also show some contradictions with 
respect to other observations in the literature. Whereas some have found an expansion 
of disability in the Netherlands at advanced ages, we found a stable number of years with 
disability in both men and women, which persisted up to age 80.[33] Most probably this 
is due to a difference in the level of disability; mild disability increased, whereas severe 
disability reduced over time.[34,35] Only for women life expectancy in good self-reported 
health decreased in the oldest old. In a cohort of 85 years old Dutch women similar 
results have been found.[36] 
During the last thirty years in the Netherlands, the gap between men and women in 
healthy life expectancy at birth has increased. In 1985, women had a higher life expectancy 
than men but the two sexes lived similar years in good health. Life expectancy without 
chronic diseases, however, decreased much more in women, leading to women having 
an almost seven years lower life expectancy without chronic diseases compared to men 
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in 2010. In the oldest old, women have a higher life expectancy, but life expectancy 
without chronic diseases is the same in men and women. 
The sex difference in the proportion of years lived in good health, has also been observed 
in other countries and described as the male-female health-survival paradox.[37-40] 
Although women have a higher total life expectancy, men live longer in good health, 
which persists up to old age. The mechanisms behind this paradox are only partly 
known. The prevalence rates of musculoskeletal pain for example are higher for women 
compared to men, which has also been found in Dutch women.[41-43] In accordance, 
other observations from a study in multiple countries also showed that women have 
higher prevalence rates of non-lethal chronic diseases.[26] While the male-female health-
survival paradox has further widened in the trajectories of life expectancy at birth, in the 
oldest old women have a similar healthy life expectancy than men in the Netherlands. 
This indicates that the sex difference in healthy life expectancy should be interpreted as 
an increased prevalence of chronic condition of middle-aged women. 
All in all, our results show healthy life expectancy and total life expectancy at birth are 
continuously increasing for both men and women. However, more years are lived with 
disease which could reflect both early diagnosis and changed life styles. Sex differences 
in total life expectancy remain at old age, but men and women can expect a similar 
number of years of healthy life expectancy at age 80. At the end of life there remains a 
period of frailty that can be postponed, but not further compressed. Hence, the need for 
care will be concentrated at the end of life. From an economic perspective, this indicates 
that the highest costs will not increase with the increase in life expectancy and will be 
fixed at a period at the end of life, which is in line with earlier studies.[44,45] This is of 
prime importance as it has major implications for pensions, health care costs, and well-
being. What biological or social mechanisms are behind the striking sex-difference in 
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Chapter 6
bETTER HEALTH, LONGER LIVES




Life expectancy has steadily increased with around 2.5 years per decade over the past 
150 years and continuous to do so at a similar rate.[1] Before 1950, the increase in life 
expectancy was primarily driven by reductions in child mortality. During the last decades, 
however, the increase in life expectancy is mainly the result of mortality reductions at 
old age.[2] Better living conditions and hygiene have saved us from an early death, while 
incremental health care innovations have brought us an old age. 
When confronted with the increasing life expectancy, individuals are uncertain whether 
they would like to live longer than the nowadays average of 80 years. In sharp contrast 
almost everybody prefers to maintain a good health when growing old. This notion is 
even more pertinent as not only life expectancy has greatly increased, but the prevalence 
of life-style related diseases such as cardiovascular disease, obesity and diabetes as 
also increased.[3] It seems, that the increase in longevity comes at a cost of ill health. 
Here however, we reason that this conclusion is unjust and that we live longer in better 
health. To unravel this paradox, we should not only consider life expectancy with and 
without chronic diseases, but also life expectancy with and without disabilities, and life 
expectancy in self-perceived health. 
For several decades in the Netherlands, life expectancy without disability and life 
expectancy in good self-perceived health have increased parallel to the increase in life 
expectancy.[4] During the same period life expectancy without chronic diseases has 
decreased, in line with the international trends. There is a sound logic that the reduction 
of years without chronic diseases can coincide with living in better health for longer. First, 
changes in life-style have increased the prevalence of hypertension, obesity, diabetes 
and other life-style related diseases. Second, ailments associated with ageing are 
diagnosed earlier due to increased health awareness and screening. But third, treatment 
outcomes of disease states are ever improving and permanent damage is increasingly 
being prevented. The net result is that life-style changes and earlier diagnosing have 
contributed to an increased number of years ‘suffering’ from chronic diseases, but at the 
same time appropriate treatment of these ailments provided us with an extra number of 
years without disabilities. We now live healthier for longer than ever before. 
Some have a more pessimistic view and argue that longer lives bring with it worsening 
health.[5] This is an often-made misinterpretation when looking at trajectories of the 
number of years with and without chronic diseases only. Being diagnosed with disease by 
the doctor is not the same as being disabled. To illustrate this stand, we take hypertension 
as an example, the occurrence of which has greatly increased over the last decades. With 
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improved screening algorithms for hypertension, we managed to reveal the ailment, to 
treat it and to delay the occurrence of cardiovascular disease. By preventing stroke and 
heart failure at an early age, disability and death are postponed to a higher age. When 
diagnosed with hypertension, one is labelled as being diseased but it allows for adequate 
intervention. As a result of our impetus, life expectancy in good self-perceived health is 
still on the increase.
One thing that should be noted is that there is a considerable female-male difference 
in morbidity, which has been observed in various countries and persists up to old age.
[4] Although women have higher life expectancy than men, they proportionally live more 
years in ill health. There is little known about the exact mechanisms behind this sex 
difference. It is partly explained by differences in the prevalence of non-lethal chronic 
conditions. Women for instance suffer more from osteoporosis and musculoskeletal 
disorders. Furthermore, it has been argued that women have a shorter ‘patient delay’, 
are more rapidly seeking medical attention and are consequently diagnosed with disease 
earlier than men. 
It is a daunting task to predict the shape of health and disease trajectories in the future, 
but past performance in healthy life expectancy allows some probabilistic conclusions. 
People born today, will survive up to very old age while maintaining a good self-perceived 
health. This has important implications for society. One of the fears of our ageing 
populations is that this fuels an explosion of health care expenditures. The highest costs 
appear at the end of life, to accommodate disability and frailty, but as the data show, this 
number of years is not likely to expand. At the end of life there will remain a period of 
frailty that cannot be further compressed, but is delayed to later age. It is a well-known 
fact among health economists that the increase in expenditures is primarily driven by 
health care innovations. 
It is a privilege to live in a society where so many people live up to old age and never 
before have we enjoyed so many years without disability that are well perceived. Some 
argue that this longevity revolution becomes untenable, as social and pension systems 
will fail. The new insight is that the extra years that we have gained are good years and 
need to be exploited. It allows people to stay active and be vital for a longer period of their 
life course. It is a challenge to rearrange our societies in such a way that older people can 
contribute and participate for longer. Postponing pension age, for example, can help to 




It is time people realise that they can foresee a healthier and longer life and plan their life 
course accordingly. 
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Steady growth in human life expectancy has been a key feature of the last century, with 
projected further increases likely to have enormous impacts on societies world-wide. 
Despite the significance of these changes, our understanding of the factors shaping this 
trend is incomplete. During most of the historical increase, by far the major influence 
was progressive decline in early and mid-life death rates, due to reduction in premature 
deaths, caused chiefly by infection. Recent decades have seen the emergence of a new 
driver of increasing longevity – declining mortality among those who are old already, 
pointing to greater malleability in human ageing than had been foreseen. There is still 
debate, however, how much of this decrease in old-age mortality is due to a better early-
life environment and how much due to improved conditions in late life. A unique resource 
exists in the case of Japan, where material circumstances for the general population 
were consistently adverse through the early decades of the 20th century, but improved 
rapidly after 1950. Here we compare the Japanese birth cohorts of 1900, 1910 and 1920 
and follow their period and cohort mortality trends. The results show that cohorts with 
similar environments early in life have very different mortality trajectories in old age. 
This strengthens the expectation that preventive measures in later life can deliver great 
benefit, while not contradicting the importance of life course approaches to improving 
health and wellbeing.
99
Malleability of human ageing
INTRODUCTION 
Over the last century mortality in developed countries has decreased at all ages.[1-
3] Initially, the largest decrease was in child mortality and only in recent decades has 
the decrease been predominantly at old age.[4,5] The determinants of the decrease in 
child mortality are well known, and include improved hygiene, vaccinations and other 
preventive measures. Exposures to infectious diseases and to poor nutrition early in 
life, including the period in utero, have been linked with mortality in old age.[6-11] In the 
unusual case of individuals who were prenatally exposed to famine during the Dutch 
Hunger Winter in 1944-45, when for about six months average daily adult intake was 
reduced to around 700 kcals, persistent epigenetic differences have been detected six 
decades later.[12] Individuals exposed peri-conceptionally to famine displayed, in their 
sixties, significantly less DNA methylation of the imprinted IGF2 gene that is involved in 
human growth and development. In this accident of history the timing of the nutritional 
stress could be determined with precision, and it is striking that individuals similarly 
exposed to the famine but during late gestation, did not show persistent epigenetic 
differences. While the evidence that developmental and early-life events can influence 
long-term health in rodents and humans is incontrovertible,[13-16] much remains to be 
learnt about the extent and scale of such effects within the broader context of increasing 
human life expectancy. Furthermore, intervention strategies based solely on targeting 
developmental factors are of little use to the growing numbers of older adults.
Establishing the contribution of factors acting directly on mortality in later life is 
challenging. In most countries, improvements in living conditions have occurred relatively 
smoothly over time, so that the cohorts now reaching old age will have benefited from 
changes that have occurred throughout the life course. There are, however, instances 
where changes have been more sudden. A study of changes in old-age mortality in East 
Germany after reunification with West Germany has shown rapid convergence of death 
rates in the two populations, rates in the East falling within little more than two decades 
to match those in the West.[17,18] However, this was only seen at very high age, when 
mortality rates always converge, and there is still some who argue that old-age mortality is 
biologically fixed.[19-21] Data from smoking cessation in old age does suggest, however, 
that health benefits can still be achieved, even when the anti-smoking intervention was 
introduced in old age.[22]
A striking instance of transition to a long-living population structure is seen in Japan, 
which in recent years has led the world in life expectancy. Although many countries that 
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experienced development through the 20th century have witnessed some features of 
the same transition, the case of Japan is exceptional because of the relative uniformity 
of living conditions for the general population during the first half of the 20th century, 
as evidenced by mortality statistics, followed by the rapid pace of improvements after 
1950. Aspects of Japanese longevity are notably different from that in other countries, 
specifically the relatively small range of socioeconomic differences and the greater 
prominence of stroke as compared to heart disease.[23] Nevertheless, Japan provides an 
intriguing “natural experiment” to examine impacts of health improvements at different 
stages in the life course which can reasonably be expected to have general relevance for 
the broader biology of human ageing and longevity.
MATERIALS & METHODS 
We used Japanese period and cohort mortality data for the study. Period mortality data 
and cause-specific mortality data were retrieved from the publicly available ‘Historical 
Statistics of Japan’ of the Japanese Ministry of Health, Labour and Welfare. Period 
mortality data were accessible for the years 1899-1903, 1909-1913, and 1921-1925, with 
a 1x5 age-year interval. We employed these mortality data as an approximation to 1900, 
1910 and 1920 period mortality data. We recognized issues on these official mortality 
data and studies revising these mortality data, notably by Mizushima.[24] However, the 
patterns of revised age-specific mortality rates were not significantly different from the 
official mortality data when three periods were compared. The cohort mortality data were 
obtained from a study conducted by Nanjo and Yoshinaga,[25] and were available with a 
1x1 age-year interval. 
All calculations were performed on publicly available population data. No participants 
were recruited for this study. Ethical approval was therefore not considered necessary to 
study population mortality and morbidity statistics.
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RESULTS 
Figure 1 shows age-specific period and cohort mortality rates for the Japanese birth 
cohorts of 1900, 1910 and 1920, using publicly available data from the Historical Studies 
of Japan (Japan, 2011). Looking at period mortality, the profiles in 1900, 1910 and 1920 
were almost identical for all age categories. 
Figure 1. Period and cohort annual mortality rates for a) females and b) males. ASMR denotes 
Age-Specific Mortality Rate. 
We can thus use these data to compare period and cohort mortality rates of three 
populations that were similarly exposed to an adverse environment early in life and which 
began to experience a rapidly improving environment at age 30, 40 and 50 years of age, 
respectively. These three birth cohorts had similar mortality rates at younger ages, only 
around the age of 10 years the mortality in 1910 and 1920 was lower compared to 1900. 
The trends started to follow complete separate trajectories at middle age as conditions 
improved, and these differences persisted into old age. On closer observation, the 1920 
birth cohort showed a mortality peak around the age of 25 years due to World War II, 
followed by a subsequent decrease of mortality before a steady increase with age. The 
1910 and 1900 birth cohorts showed similar patterns, with war-related mortality peaks 
around ages 35 and 45, respectively. 
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To study further the mortality differences at middle and old age as found in the cohort 
mortality data, we plotted the differences in cohort mortality rates of the 1910 and 1920 
cohorts compared to the mortality rates of the 1900 cohort, shown in Figure 2. 
Figure 2. Cohort mortality rate differences of the 1910 and 1920 birth cohorts when compared to 
the 1900 birth cohort, for a) females and b) males. 
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With exception of infant mortality (age 0), the mortality rates of the 1910 and 1920 birth 
cohorts were very similar to the mortality rates of the 1900 cohort at younger ages, for 
both females and males. However, from 1950 onwards, with the improvement of the 
environment after the war, the mortality rates were considerably lower for the more 
recent birth cohorts. For the 1910 cohort, the mortality difference started at age 40 and 
persisted up to old age. The 1920 birth cohort started to diverge at age 30 and shows the 
strongest mortality decrease at old age. 
In addition to the all-cause mortality data, it is important to consider changes in causes 
of death. Table 1 presents the cause-specific death rates of the age group 65-75 years 
for the periods 1965-1974, 1975-1984 and 1985-1994, respectively, corresponding to the 
cohorts born in 1900, 1910 and 1920. For individuals born in 1920, most cause-specific 
death rates (cerebrovascular disease, heart disease, tuberculosis, peptic ulcer, accidents 
and suicides) were lower than in the 1900 birth cohort. The reduction in mortality was 
most pronounced for deaths due to cerebrovascular disease. Only the mortality rates 
due to smoking-related malignancies (trachea, bronchus and lung) were higher for the 
1920 cohort. Nevertheless the overall mortality of malignancies was lower for the 1920 
birth cohort.
Table 1. Cause-specific mortality rates at age 65-75 years
Causes of death                                      1900 cohort              1910 cohort               1920 cohort
Cerebrovascular disease 1142 610 277
Heart disease* 464 411 314
Malignant neoplasm 744 719 688
   Smoking related** 86 152 141
   All other 658 567 547
Tuberculosis 86 33 11
Peptic ulcer 47 21 8
Accidents 84 59 58
Suicides 44 39 29
Mortality rates are per 100,000 per year, * including hypertension, **trachea, bronchus and lung. 
Table 1 is generated from cause-specific mortality rates for the birth cohorts born in 
1900, 1910 and 1920 at the age of 65 to 75 years. Consequently it consists of period 
mortality data from 1965-1974, 1975-1984 and 1985-1994, for the 1900, 1910 and 1920 
cohorts respectively. The cause-specific death rates were calculated per 100,000 persons 
per year, by dividing the total number of deaths due to a specific cause, by the population 




Our analysis of these Japanese data reveals that cohorts with similar environmental 
conditions early in life had very different old-age mortality trajectories, when exposed 
to environmental improvements at middle age. Mortality of the 1920 cohort was 
significantly lower compared to the cohorts from 1900 and 1910. This difference was 
mainly due to large reductions in cerebrovascular disease, which was the major cause of 
death in Japan. These findings strongly suggest that a large part of the mortality benefit 
is through old-age plasticity supporting growing recognition of the malleability of human 
ageing.[27] The contrary view – that old-age mortality is essentially fixed – is still held, 
however, and underlies, for example, the concept of “compression of morbidity” which 
suggests that the goal of age-related medicine should be to postpone as far as possible 
the onset of diseases within the fixed human lifespan,[28] at least until such time as 
science can slow down the ageing process itself.[20,21,29-31]
In view of the scale of the societal impacts of increasing human life expectancy, it 
remains important to establish the mechanisms that underlie the ongoing declines in 
death rates at the oldest ages, which in general show associations both at international 
level with wealth as measured by gross domestic product[32] and intra-nationally with 
socioeconomic status.[33] In Japan it is clear that socioeconomic conditions improved 
rapidly after 1950, but the ‘proximate’ causes that mediate between wealth and health 
in reducing mortality are less clear. One possibility is simply that better medical care 
interventions became available, as in the example of cardiovascular disease management.
[34] Improvements in healthcare could explain the found reduction in cerebrovascular 
disease, which has been suggested by others as well.[23] The potential importance of 
medical care to falling mortality is, however, commonly over-stated.[35] Additionally, in 
the case of Japan, a significant step in reducing social inequalities was the introduction 
of the universal coverage of health insurance in 1961.[36] It can be argued that more 
universal access to existing medical care and preventive interventions may have played 
a part.
An alternative possibility is that improved living conditions act systematically on the 
array of factors that either exacerbate or improve the progressive accumulation of various 
forms of damage. That is, the improvement might arise not because diseases are treated 
better or more universally, but because diseases themselves progress more slowly, or 
are ameliorated by improved general conditions. For example, many deaths attributed to 
heart disease and stroke can be identified as proximate consequences of cold exposure 
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in winter.[37] Amelioration of cold exposures with improving social conditions may 
thus have an impact upon many specific causes of death, without any change in the 
classical risk factors or treatments of those specific causes. Older people also suffer 
extensive co-morbidity – for example in one detailed study of a 1921 birth cohort of 85-
year olds in Newcastle-upon-Tyne, the majority of participants had between 4 and 6 
age-related diseases.[38] It would not be at all surprising to see environmental and social 
improvements impacting upon several or all such co-morbidities simultaneously.
Finally, it is possible that a general improvement in environment, living conditions and 
social wellbeing might impact upon the accumulation of molecular and cellular damage 
that is thought to constitute the intrinsic ageing process.[39] That is, ageing itself might 
be slowed from different ages in the different cohorts considered. Such an explanation, 
which involves the diverse effects of nutrition, lifestyle, occupation etc. interacting with 
biochemical stresses and repair mechanisms could be compatible with the strong 
socioeconomic gradients seen in health and life expectancy. However, although not 
undisputed,[40,41] it is considered that the slope of log mortality rates is an indicator of 
the population rate of ageing,[42] and it should be noted that the progressive reductions 
of risk between the cohorts reported here bring about either a parallel reduction or a 
small increase in the gradient of the log-mortality slope. 
In conclusion, cohorts with similar early life environments have very different mortality 
trajectories in old age, indicating that old-age mortality is much more malleable than 
commonly thought. This strengthens the expectation that interventions in later life, 
which include lifestyle (especially exercise), nutrition and proactive health screening with 
preventive medical treatments such as statins and control of moderate hypertension, 
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Objective: Physical exercise associates with lower mortality risk and is thus recommended 
by public health organisations all over the world. High intense exercise also places great 
strain on the body and these detrimental effects could counterbalance the health benefit.
Design: Retrospective cohort study in former Olympic athletes for all cause mortality.
Participants: We included 9,889 athletes who participated in the Olympic Games from 
1896 to 1936, representing 43 types of disciplines with different levels of cardiovascular, 
static and dynamic intensity exercise, high or low risk of bodily collision, and different 
levels of physical contact.
Results: Hazard ratios (HR) for mortality among athletes from disciplines with moderate 
cardiovascular intensity (HR 1.01, 95% confidence interval [95% CI]: 0.96 to 1.07) or high 
cardiovascular intensity (HR 0.98, 95% CI: 0.92 to 1.04) were similar when compared 
to athletes from disciplines with low cardiovascular intensity. The underlying static and 
dynamic components in exercise intensity revealed similar non-significant results. We 
did observe increased mortality among athletes from disciplines with a high risk of bodily 
collision (HR 1.11, 95% CI: 1.06 to 1.15) and with high levels of physical contact (HR 1.16, 
95% CI: 1.11 to 1.22). In a multivariate analysis, the effect of high cardiovascular intensity 
remained similar (HR 1.05, 95% CI: 0.89-1.25). The increased mortality associated with 
high physical contact persisted (HR 1.13, 95% CI: 1.06-1.21), however, bodily collision 
became non-significant (HR 1.03, 95% CI: 0.98-1.09), as a consequence of its close 
relationship with physical contact.
Conclusions: Among former Olympic athletes, engaging in disciplines with high intensity 
exercise did not bring a survival benefit when compared to disciplines with low intensive 
exercise. Those who engaged in disciplines with high levels of physical contact suffered 
an increased mortality later in life.
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INTRODUCTION
Public health associations recommend physical exercise since it is associated, amongst 
others, with lower mortality risks, better mood and cognition, and lower prevalence of 
cardiovascular disease.[1-7] However, when Pheidippides ran from Marathon to Athens 
in 490 BC to announce the Greek victory on the Persians, he died on arrival. As his case 
illustrates, exercise of high intensity can also place great strain on the body and can 
cause serious injuries and damages.[8] Key is whether regular high intensity exercise is 
associated with lower or higher mortality risk. When the first modern Olympic Games 
were held in Athens in 1896, including a marathon run to Athens, it was decided to 
shorten the distance with the death of Pheidippides in mind. The nowadays distance 
of 42 kilometres and 195 meters was only later determined during the third Olympics 
in London, when the royal family requested to extent the run from the start at Windsor 
Castle to the royal stage in the White City Stadion. This year the Olympic Games were 
back in London again, but it is still debated whether high intensive exercise, as in many 
Olympic disciplines, is beneficial for reducing mortality risk.[9-10]
The effect of high intensive exercise on mortality later in life has mostly been studied 
among professional athletes, using the general population as a control group. The 
outcomes from these studies differ; some did not find a survival benefit, whereas others, 
showed lower mortality in athletes than in their non-athletic counterparts from the 
general population.[11-24] It is well possible that the lower mortality risk of professional 
athletes is due to specific social and psychometric characteristics and it remains to be 
elucidated whether for athletes, high intensive exercise brings a survival benefit or an 
increased mortality risk.
Here we have analyzed mortality patterns in a large historic cohort of athletes who had all 
participated in the Olympic Games from 1896 to 1936 but performed at different levels of 






In May 2011, we retrieved a cohort of 21,127 former Olympic athletes from the online 
Sports Reference Database, the largest online database with Olympic athletes, which is 
continuously updated.[25] Figure 1 summarizes the inclusion process in a flow diagram. 
We included 9,889 former Olympic athletes, born between 1830 and 1910 with a known 
age-at-death, who participated in at least one of the Summer Olympic Games between 
1896 and 1936. We excluded 2,162 athletes from nine disciplines that were not mentioned 
in the classification of the American College of Cardiology.[26] We classified skeleton as 
bobsledding and polo as equestrian, due to very similar types of exercise. From 7,534 
athletes the age-at-death was unknown due to either an unknown date of birth and/or 
date of death. Finally we excluded 1,542 participants born after 1910, since athletes born 
afterwards could possibly be still alive. 
Figure 1. Flow diagram illustrating the inclusion of former Olympic athletes in the study.
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Classification of Olympic disciplines
The 43 Olympic disciplines were classified according to the classification system of the 
‘8th Task force on the classification of sports’ by the American College of Cardiology.
[26] Classification of the cardiovascular intensity sums a static component reflecting 
maximal voluntary muscle contraction, and a dynamic component reflecting maximal 
oxygen uptake and both were categorized at three levels of intensity: low, moderate and 
high. They also defined three levels of static and dynamic intensity: low, moderate, and 
high. When an athlete had participated in multiple disciplines, we categorized him/her 
in the discipline with the highest cardiovascular score. The risk of bodily collision was 
classified also, by the American College of Cardiology.[26] Finally, we have classified 
the various disciplines as low (non-contact), moderate (limited-contact) and high 
(full-contact) sports, according to the classification of contact sports of the American 
Academy of Paediatrics.[27] The levels of exercise intensity were similar in athletes who 
were included and excluded in the present analysis (data not shown).
 
Statistical analysis
We have calculated hazard ratios for all cause mortality using a left-truncated Cox 
proportional hazards model entering participants at the age of first participation in 
the Olympic Games. All analyses were adjusted for sex, year of birth and nationality. 
Calculations were performed with Stata 11 (StataCorp. 2009. Stata Statistical Software: 
Release 11. College Station, TX: StataCorp LP). 
RESULTS
We included 9,889 athletes from 43 different Olympic disciplines that were classified 
in various categories of intensity of exercise, risk of bodily collision, and the level of 
physical contact. Table 1 summarizes the characteristics of these 43 Olympic disciplines. 
In addition, figure 2 shows all 43 disciplines stratified for the level of static, dynamic and 


















Alpine Skiing 27 (0.3%) High High Moderate Yes High
Archery 66 (0.7%) Low Moderate Low No Low
Basketball 26 (0.3%) High Moderate High Yes High
Biathlon 8 (0.1%) Moderate Low High No Moderate
Bobsledding 91 (0.9%) Moderate High Low Yes Moderate
Boxing 277 (2.8%) High High High Yes High
Canoeing 28 (0.3%) High High High No Low
Cricket 14 (0.1%) Low Low Low No Moderate
Cross-country skiing 152 (1.5%) Moderate Low High No Moderate
Curling 12 (0.1%) Low Low Low No Low
Cycling 388 (3.9%) High High High Yes Moderate
Decathlon (athletics) 86 (0.9%) High High High No Moderate
Diving 157 (1.6%) Low Moderate Low Yes High
Equestrian 315 (3.2%) Low Moderate Low Yes Moderate
Fencing 561 (5.7%) Low Low Moderate No Moderate
Field Hockey 159 (1.6%) Moderate Low High Yes High
Figure Skating 90 (0.9%) Moderate Moderate Moderate No Moderate
Golf 65 (0.7%) Low Low Low No Low
Gymnastics 687 (6.9%) Moderate High Low Yes Low
Handball 21 (0.2%) High Moderate High No High
Ice Hockey 202 (2.0%) High Moderate High Yes High
Jumping events (athletics) 343 (3.5%) Moderate Moderate Moderate No Moderate
Lacrosse 32 (0.3%) High Moderate High Yes High
Marathon (athletics) 203 (2.1%) Moderate Low High No Low
Middle/long-distance run-
ning (athletics)
614 (6.2%) High Moderate High No Low
Modern Pentathlon 83 (0.8%) High Moderate High No Moderate
Nordic Combined 39 (0.4%) Moderate Low High No Moderate
Polo 67 (0.7%) Low Moderate Low Yes Moderate
Race walking (athletics) 100 (1.0%) Moderate Low High No Low
Racquet 7 (0.1%) Moderate Low High No Moderate
Rowing 657 (6.6%) High High High No Low
Rugby 98 (1.0%) Moderate Moderate Moderate Yes High
Sailing 455 (4.6%) Moderate High Low No Low
Shooting 569 (5.8%) Low Low Low No Low
Skeleton 1 (0.0%) Moderate High Low Yes Moderate
Soccer 783 (7.9%) Moderate Low High Yes High
Speed Skating 72 (0.7%) High High High Yes Moderate
Sprint (athletics) 719 (7.3%) Moderate Moderate Moderate No Low
Swimming 434 (4.4%) High Moderate High No Low
Tennis 245 (2.5%) Moderate Low High No Low
Throwing events (athletics) 316 (3.2%) Moderate High Low No Low
Weightlifting 133 (1.3%) Moderate High Low Yes Moderate
Wrestling 487 (4.9%) High High Moderate Yes High
*According to the American College of Cardiology.26 ** According to the American Academy of 
Paediatrics.27
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Figure 2. The 43 Olympic disciplines classified in categories of static and dynamic intensity as 
well as three categories of low, moderate and high cardiovascular intensity (from yellow to red). 
According to the American College of Cardiology.26 
We first calculated hazard ratios for mortality dependent on different levels of exercise 
intensity. Since the participants came from different birth cohorts, we adjusted all our 
analyses for year of birth, which, as expected, was correlated with mortality. Next, we 
adjusted for sex and nationality, which were also, correlated with mortality (data not 
shown). Table 2 shows hazard ratios for mortality for different levels of cardiovascular, 
static and dynamic intensity in both the univariate and multivariate analysis. Engagement 
in disciplines with increasing cardiovascular intensity was not associated with a 
significant higher mortality risk; the hazard ratio for moderate intensity was 1.01 (95% 
CI: 0.96 to 1.07, p = 0.71) and for high intensity it was 0.98 (95% CI: 0.92 to 1.40, p = 
0.46). The multivariate analysis revealed similar results, as shown in table 2. Analysis of 
116
Chapter 8
the static and dynamic component separately, showed similar non-significant results. 
The univariate analysis showed a small beneficial effect of moderate static exercise but 
this was not reflected in a lower hazard ratio in those engaged in disciplines with high 
intensity static exercise.
Table 2. Hazard ratios of mortality for athletes in disciplines with different intensities of exercise. 
Intensity        Univariate            Multivariate
HR 95% CI P-value HR 95% CI P-value
Cardiovascular
     Low Ref. Ref.
     Moderate 1.01 0.96-1.07 0.71 1.04 0.95-1.15 0.40
     High 0.98 0.92-1.04 0.46 1.05 0.89-1.25 0.58
Static
     Low Ref. Ref.
     Moderate 0.94 0.89-0.99 0.02 0.93 0.85-1.01 0.09
     High 0.99 0.94-1.04 0.62 0.95 0.85-1.07 0.40
Dynamic
     Low Ref. Ref.
     Moderate 0.94 0.89-0.99 0.03 0.94 0.87-1.01 0.09
     High 0.97 0.92-1.02 0.19 0.94 0.83-1.06 0.34
Data are expressed as hazard ratios (HR). Univariate analysis adjusted for sex, year of birth, and 
nationality. Multivariate analysis additionally includes all types of exercise intensity (cardiovascular, 
static and dynamic intensity) in the model. 
We also studied the effect of bodily collision and physical contact on mortality (Table 3). 
Athletes engaged in disciplines with high risk of bodily collision had 11 percent higher 
mortality risk when compared to athletes who were not exposed (HR 1.11, 95% CI: 1.06 
to 1.15, p<0.001). When comparing athletes who had performed in disciplines with 
various levels of physical contact it was shown that, those who participated in sports with 
moderate contact only, did not suffer a higher mortality risk. However, athletes who were 
exposed to high levels of physical contact had a 16 percent higher mortality risk, when 
compared to athletes with low physical contact (HR 1.16, 95% CI: 1.11 to 1.22, p<0.001). 
These higher mortality risks remained similar in the multivariate analysis whereas the 
hazard ratio for bodily collision became non-significant.
We have additionally performed similar analyses as above in various subgroups: 
males only, deaths after age 50, born before 1900 and born after 1900. The results are 
presented in figure 3. In none of the subgroups, exercise at high cardiovascular intensity 
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was associated with a mortality risk reduction. However, when studying the risk of bodily 
collision and high physical contact we found a significant higher mortality risk in all these 
subgroups. 
Table 3. Hazard ratios of mortality for athletes in disciplines with different risk of bodily collision 
and physical contact. 
Sport type Univariate            Multivariate
HR 95% CI P-value HR 95% CI P-value
Bodily collision
     No Ref. Ref.
     Yes 1.11 1.06-1.15 <0.001 1.03 0.98-1.09 0.25
Physical contact
     Low Ref. Ref.
     Moderate 0.97 0.93-1.02 0.25 0.96 0.92-1.01 0.16
     High 1.16 1.11-1.22 <0.001 1.13 1.06-1.21 <0.001
Data are expressed as hazard ratios (HR). Univariate analysis adjusted for sex, year of birth, and 
nationality. Multivariate analysis additionally includes both bodily collision and physical contact in 
the model. 
 
Figure 3. Hazard ratios of mortality (95% confidence intervals) in former Olympic athletes 
dependent on cardiovascular intensity, bodily collision and physical contact. Analyses adjusted for 




Our results show that former Olympic athletes who engaged in disciplines with high 
cardiovascular intensity had similar mortality risks when compared to athletes from 
disciplines with low cardiovascular intensity. This would indicate that engaging in cycling 
and rowing (high cardiovascular intensity) had no added survival benefit when compared 
to playing golf or cricket (low cardiovascular intensity). 
Although it is a daunting task to compare nowadays sport activity with that during the 
first series of the games, the current analysis is sobering for all those athletes that trained 
so hard to qualify for the London Olympics in 2012. Moreover, our analyses do point to 
a potential risk for those engaged in disciplines with a high risk of bodily collision and/or 
high levels of physical contact. As the higher mortality risk persisted when studying death 
after age 50 this increased risk could not be explained by the death of young athletes due 
to trauma. We consider it more likely that the higher mortality risk reflects the effect of 
gradual accumulation of multiple bodily injuries during sport activities. In line, previous 
studies have shown that bodily collisions and or fierce physical contacts are responsible 
for a large proportion of the total burden of injuries.[8,28] Next to the direct impact, these 
injuries may have long lasting detrimental effects and aligns with the generalized theory 
of ageing. For instance, repetitive head blows, especially in boxers, are associated with 
cognitive impairment, early onset dementia, and a reduced life expectancy.[29-30] 
 
Our findings stand in contrast to several other studies showing late-life mortality benefit 
in very well trained athletes.[31-34] A possible explanation could be that these studies only 
included moderate exercise intensity. Other studies however, described a late-life survival 
advantage for endurance athletes who had trained at high physical intensity.[22-24,35] 
But, all previous observations may suffer a bias, as trained athletes differ more from the 
general population than in physical fitness only. We consider the present comparison of 
former Olympic athletes who performed their sports at different physical intensity more 
robust than a comparison between trained athletes and individuals from the population 
at large. This interpretation is strengthened by the fact that outcomes were congruent in 
all domains of physical intensity, ie. cardiovascular, static and dynamic intensity.
In this study, we used data from athletes who participated in the Olympic games from 
1896 until 1936. Hence, outcomes are considered to reflect late-life consequences 
of intensive exercise programs that were en vogue 70 to 110 years ago. Since then, 
training programs, especially on a (semi)professional level, have changed substantially. 
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Nowadays top-athletes not only train more often and more intense, trainings have also 
become more individualized and specifically focused. Moreover, medical care to prevent 
permanent damage is undoubtedly better, and could explain why in the past potential 
benefits of intensive physical training where overwhelmed by tradeoffs later in life. We do 
not have access to any data that allows for a valid comparison of use of anabolic steroids 
and other stimulating substances, but many would argue that the use was probably less 
prevalent in the past than it is now. For all of these reasons one should be carefull to 
extrapolate the present findings to the late-life effects of present day training schemes. 
Regarding the negative impact of bodily collision and fierce physical contact, it is 
important to realize that present sporting activities have become far more extreme 
with regard to velocity, g-force and other mechanical strains. Collisions and physical 
injuries could therefore have more impact nowadays, despite better protective aids and 
medical treatment. Our findings could well underestimate the late-life effects of the 
gradual accumulation of permanent damage due to repeated collisions and injuries 
that nowadays top-athletes are exposed to.This having said, there are several potential 
confounders that could decrease or further increase the hazard ratios for mortality that 
we have found. These include unknown factors such as the total number of years spent 
in training, age at which intensive training ceased, the intensity of exercise after the 
athletes withdrew from competitive sports, specific behaviour in specific types of sports, 
specific personal characteristics depending on the type of sports, etc. Also, it should be 
noted that beneficial effects of exercise could be counterbalanced by detrimental effects 
of (acute) cessation of physical exercise resulting in a net neutral effect. 
 
Although we did not find arguments that former Olympic athletes from disciplines with 
high intensive exercise suffer a higher mortality risk, one should have a moment of 
caution before engaging in disciplines with risk of bodily collision and or fierce physical 
contact. This notion may help to explain an historical fact. Before Pheidippides exclaimed 
νικωμεν (we have won) and collapsed, he had not only ran from Marathon to Athens, but 
had fought in the battle of Marathon before that. It is tempting to speculate that it was 
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ARTS AND AGEING; LIFE EXPECTANCY OF 
HISTORICAL ARTISTS IN THE LOW COUNTRIES 
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Practicing arts has been linked to lowering stress, anxiety and blood pressure. These 
mechanisms are all known to affect the ageing process. Therefore, we examine the 
relation between long-term involvement in arts and life expectancy at age 50 (LE50), in 
a cohort of 12,159 male acoustic, literary and visual artists, who were born between 1700 
and 1899 in the Low Countries. We compared the life expectancy at age 50 of the various 
artists with the elite and middle class of that time. In the birth cohorts before 1850, 
acoustic (LE50:14.5-19.5) and literary artists (LE50:17.8-20.8) had a similar life expectancy 
at age 50 compared to the elite (LE50:18.0-19.0). Only visual artists (LE50:15.5-17.1) had 
a lower life expectancy at age 50 compared to the elite at that time. For the most recent 
birth cohorts from 1850 through 1899, the comparison between artists and the elite 
reversed and acoustic and literary artist had a lower life expectancy at age 50, while visual 
artists enjoyed a similar life expectancy at age 50. Although artists belonged to the middle 
socioeconomic class and lived predominantly in urban areas with poor living conditions, 
they had a life expectancy similar to the elite population. This is in line with observed 
favourable effects of practicing arts on health in the short-term. From our historical 
analysis, we hypothesize several mechanisms through which artistic creativity could 
influence the ageing process and life expectancy. These hypotheses, however, should be 




Since ancient times arts have been used for therapeutic purposes to enhance health. 
Hippocrates played music for his mental patients and Aristotle described music as 
a force that purified the emotions [1]. In the thirteenth century, Arab hospitals also 
contained music-rooms for the benefit of the patients [2]. Since that time, colleges and 
universities developed programs to train musicians how to use music for therapeutic 
purposes. Also today, acoustic, literary and visual arts are used to improve the health 
conditions in chronically ill patients [3-5]. Current research has shown favourable effects 
of engaging in arts on health, via several mechanisms such as reducing stress, anxiety, 
pain and blood pressure or improving the immune response and quality of life [6]. Via 
such mechanisms, artistic interventions can increase general health, decrease doctor 
visits, and reduce medication use and improve strategies to cope with chronic diseases 
[3,6]. 
Many of the above described effects of arts on health, are also known to affect the ageing 
process. High levels of stress, blood pressure or anxiety, have been found to increase the 
risk of ageing-related diseases, such as cardiovascular disease [7,8]. In addition, lower 
stress and anxiety are strongly linked with better well-being, which again is associated 
with longevity [9-14]. It is therefore of interest to study the long term effects of performing 
arts on life expectancy. Up to now, this has been only studied on the short term, and the 
effect of practicing arts on ageing and life expectancy remains unknown. One earlier 
historical study [15] has shown that visual artists enjoyed a life expectancy that was 
similar to the life expectancy of the elite, but the question remained whether this was due 
to their artistic profession or due their socioeconomic status or other determinants. No 
studies have been performed on the life expectancy of other artists. 
Therefore, we studied the relation between long-term involvement in arts and life 
expectancy at age 50, in a unique historical cohort of 12,159 male artists from different 
disciplines, who were born between 1700 and 1899. By studying different groups and 
types of artists we gain more insight in whether the observation that visual artists have 
a similar life expectancy as the elite is a true ‘art-effect’ or an ‘artefact’ of socioeconomic 
status, selection or other another determinant. This is the first time that the historical 
life expectancy of different artists is studied in relation to each other and the elite. The 
aim of this study was to examine ageing-related or senescent mortality, which increases 
with age more than non-ageing, accident- related mortality, which is also described as 
background mortality that does not rise with age [16]. A better understanding of the 
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possible favourable effects of engaging in arts on ageing is of great interest, since it could 
point to possible public health interventions that not only increase the length but also 
the quality of life.
MATERIALS & METHODS
Data
We retrieved data from three different databases. Because of the small number of 
female artists in historical times, we have only studied male artists. Also, because we 
are interested in ageing-related or senescent mortality and not in child or background 
mortality, we confined the analysis to people who lived at least till 25 years of age.[16] The 
Dutch Music Institute (Nederlands Muziek Instituut, The Hague) [17] provided data of 
1,543 acoustic artists, comprising both composers (81.7%) and musicians (19.3%). From 
the total of 1,543 acoustic artists, the sample was reduced by removing the individuals 
for which the birth year was unknown (125) and additionally those for whom the year of 
death was unknown (211). Finally, because we place the restriction that the artists should 
have survived up till age 25, we removed 54 acoustic artist who died before age 26, 
resulting in a remaining group of 1,153 acoustic artists that we included in our analysis. 
Next, the Biographic Portal (Biografisch Portaal), a national institute which collects 
scientific information about leaders and prominent figures from Dutch history, provided 
a group of 742 literary artists [18]. The group of literary artists consists mainly of poets. 
From the total of 742 literary artists, the sample was reduced by removing 67 individuals 
who were born before 1700 and 75 were born after 1899. From the remaining 600 literary 
artists, we excluded 92 women (we only focus on men). Next, 3 literary artists died before 
age 26, which resulted in a final sample of 505 literary artists. We derived data of 13,942 
visual artists from the RKD-artists database, hosted by the Dutch Institute for Art History 
(Rijksbureau voor Kunsthistorisch Documentatie, The Hague) [19] This database exists 
of painters (87,8%) and sculptors (12,2%). For an extensive description of the visual 
artist data we refer to an earlier study [19]. From the total of 15,419 visual artists Van 
Poppel et al. [15] used, we removed those who were born before 1700 (3,339) and born 
after 1899 (1,477) and those who died before age 26 (102). We ended up with a sample 
of 10,501 visual artists. Finally, we obtained 9,388 elite individuals from the Biographic 
Portal [18]. This group contained individuals from several occupational fields, including 
church, education, science, government, nobility and royals, trade and industry, defence 
forces, judicial system and colonial overseas. The largest subgroup among the elite was 
from Church, i.e. 2,765 people (31.6%). The majority of all groups consisted of men 
(78.4-96.4%). From the total of 9,388 elite individuals, we excluded 2,697 who were 
127
Arts and ageing
born before 1700 and 579 who were born after 1899. From the remaining 6,112 elite, 
we excluded 167 women. From the residual 5,945, 20 died before age 26 and we finally 
included 5,925 in our analysis. 
 
Historical data on individuals from the middle class were only available for the most 
recent birth cohorts from 1850-1899. We use data that relate to the country as a whole, 
thus we can take into account the situation of people living in a variety of ecological, 
social, and economic circumstances, covering the countryside and small and big towns. 
For this study we have used data collected in the framework of the Historical Sample of 
the Netherlands (HSN). From the total of 3,996 individuals in that sample, 1,101 were 
classified as being middle class. Of these individuals 24 died before age 26 and hence we 
included 1,077 people in our analysis. For a detailed description of these data and how 
the socioeconomic status was assessed we refer to an earlier publication by Schenk & 
van Poppel [20].
 
All databases are available on request. The birth cohorts covered by these databases lived 
from the 18th century until the end of the 1900s. Every individual is only once assigned to 
a group in the database. Hence, there is no overlap between the groups. It is possible that 
some elite people also practiced arts occasionally, but if such an elite person practiced 
arts more professionally, he would have been in the artist-database.
 
By studying the life expectancy at age 50, we have tried to reduce the effect of background 
mortality, such as early deaths due to child disease, and at middle age and other non-
ageing related diseases. Additionally, by studying life expectancy at age 50, we overcome 
a survivor treatment selection bias , also known as ‘immortal time bias’. In the case of 
artists for instance, they have to survive up to a certain age in order to become successful 
and famous artist. A recent example from the literature is a study that suggested a 




We carried out separate analyses by four different birth cohort groups: people born 
between 1700 to 1749, born between 1750 to 1799, born between 1800 to 1849, and 
born between 1800 to 1899. The data were analyzed using Gompertz hazard models 
for each discipline and cohort separately. Based on the estimated model we calculated 
the implied life-expectancy. For the visual artists we sometimes knew only an interval, 
sometimes 10 years wide, in which they were born and/or died. We used a previously 




In analyses of human mortality a Gompertz distribution [23] is known to fit well [24-26]. 
This distribution has two parameters, a shape α and a scale parameter β. The hazard rate, 
the force of mortality, at age t increases exponentially over the life span, βαλ += tet)( . 
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Based on the observed years of birth and death we calculated the implied age of death. 
For the visual artists we sometimes knew only an interval, sometimes 10 years wide, in 
which they were born and/or died. In those situations a minimum length of life and a 
maximum length of life could be derived. When the date of birth was known exactly but 
the death was only recorded as occurring within a given interval the minimum length of 
life was calculated as the difference between the date of birth and the earliest date of 
death reported, and the maximum length of life as the difference between the date of 
birth and the latest date of death. When the date of death was known exactly but the date 
of birth was recorded as occurring within a specific time-interval, the minimum length of 
life was calculated as the period from the last possible date of birth until the date of death 
and the maximum length of life as the period from the earliest possible date of birth until 
the date of death. Finally, when both the date of birth and the date of death were known 
only approximately and both were recorded as falling within particular time intervals. In 
such cases, the minimum length of life was calculated as the period from the latest date 
of birth until the earliest date of death, and the maximum length from the earliest date of 
birth until the latest date of death. In Van Poppel et al. [15] the procedure to account for 
this type of interval censoring are discussed in detail. 
In addition, by making it a condition that an individual must have already survived to the 
age of 25, it is possible to take into account the fact that, to be recognised as an artist, 
an individual needs to have lived long enough to have produced a notable piece of art. 
To estimate the parameters of the model we maximized the joint likelihood, which is the 
product of the individual likelihood contributions. The individual likelihood contribution 
is the density for those artists whose exact date of birth and date of death were known. 
For the visual artists we accounted for the interval censoring described above, see [19] or 
the appendix. Based on the estimated parameters the life expectancy, LE
50
, at age 50 can 
be approximated very well [26]. 
where γ ≈ 0.57722 is the Euler-Mascheroni constant. The variance of the life expectancy 
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at age 50 can be approximated using the delta-method, the standard method in 
econometrics to obtain the distribution of a nonlinear combination of parameters [27]. 
Using the estimated LE
50
’s and their variance we calculated, for each cohort period and 
for each of the three artist-groups, the difference of the artist life expectancy with the life 
expectancy of the elite group (assuming independence the variance of the difference is 
the sum of the variances). The p-values of these tests are reported in Table 2.
RESULTS
We included 12,159 male artists from three different disciplines who were born between 
1700 and 1899. The numbers are summarized in table 1. In total 1,153 acoustic, 505 
literary and 10,501 visual artists were included. The elite group consisted of 5,925 
individuals, born in the same time period. The majority of the individuals (32-69%) were 
born between 1850 and 1899. Historical data on people from the middle class were only 
available for the most recent birth cohorts, born after 1850. In total we studied 1,077 
individuals from the middle class of that time. 





Visual artists Elite Middle class
Total n(%) 1,153 (100) 505 (100) 10,501 (100) 5,925 (100) 1,077 (100)
Year of birth n(%)
      1700-1749 38 (3) 17 (3) 681 (6) 940 (16)
      1750-1799 72 (6) 45 (9) 1,303 (12) 1,424 (24)
      1800-1849 243 (21) 130 (26) 2,797 (27) 1,676 (28)
      1850-1899 800 (69) 313 (62) 5,720 (54) 1,885 (32) 1,077 (100)
We analysed the life expectancy at age 50 from the various groups of artist and first 
compared their life expectancy to that of the elite. Figure 1 shows the life expectancy at 
age 50 for the birth cohorts from 1700 to 1749, 1750 to 1799, 1800 to 1849 and 1850 to 
1899. From 1700 to 1899, there has been an increase in life expectancy in all groups. For 
the middle class, data were only available for the most recent studied cohorts, in the 
figure this point estimate is shown as a star. 
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Figure 1. Life expectancy at age 50 of male artists (acoustic, literary and visual), the elite born 
between 1700 and 1899 and the middle class born between 1850-1899.
Next, we tested whether the life expectancy of the artists was different from that of the 
elite. Table 2 shows the life expectancies at age 50 of artists and elite, the standard errors 
and tests of significance. Before 1850 artists had a similar life expectancy at age 50 when 
compared to the elite of that time, except for the visual artists, who had a significant 
lower life expectancy at age 50. In the most recent period from 1850 to 1899, this pattern 
reversed and acoustic and literary artists had a significant lower life expectancy at age 50 
than the elite. Visual artists and the elite had a similar life expectancy at age 50 of almost 
25 years after 1850. Only for the latest period, data of a middle class population were 
available. During that period, the middle class had an average life expectancy at age 50 of 
22.6 years. The various artists had a higher life expectancy than the middle class at that 
time, although this reached only significance in the largest group of visual artists. 
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Table 2. Life expectancy at age 50 (LE50) of artists compared to the life expectancy at age 50 of the 
elite, who were born between 1700-1899 and to the life expectancy at age 50 of the middle class 












LE50 (SE) P LE50 (SE) P
LE50 
(SE)
P LE50 (SE) P LE50 (SE) P
1700-1749 14.5 (2.9) 0.07 20.8 (2.1) 0.17 17.1 (0.6) 0.02 18.7 (0.5) ref.
1750-1799 19.5 (1.4) 0.16 17.8 (2.1) 0.46 16.5 (0.5) <0.05 18.0 (0.4) ref.
1800-1849 17.9 (1.0) 0.14 18.3 (1.4) 0.31 15.5 (0.4) <0.001 19.0 (0.3) ref.
1850-1899 22.7 (0.6) <0.05 23.1 (0.7) 0.02 24.4 (0.2) 0.23 24.6 (0.3) ref.
1850-1899 22.7 (0.6) 0.43 23.1 (0.7) 0.26 24.4 (0.2) <0.001 24.6 (0.3) <0.001 22.6 (0.4) ref.
DISCUSSION
Between 1700 and 1849 acoustic and literary artists had a similar life expectancy at age 
50, when compared to the elite population of the Low Countries. Only visual artists had 
a lower life expectancy at age 50 in these birth cohorts. This is striking, since artists 
belonged predominantly to the middle socioeconomic class [15, 28]. In cohorts born after 
1849 acoustic and literary artists had a lower life expectancy compared to the elite, while 
visual artists enjoyed a similar life expectancy when compared to the elite. Unfortunately, 
historical data on the middle class population has not been documented. Only for the 
most recent birth cohorts we have found data, which showed that artists lived longer 
than the middle class, but this reached only significance in the largest group of visual 
artists. 
 
Our study differs from a previous study, in which artists were found to have a lower 
survival compared to popes [29]. Others have shown that visual artists had a relatively 
high life expectancy, when compared to the elite of their time, which is in line with our 
observations [15]. We studied different groups and types of artists and found that not 
only visual, but also, other artists had a similar life expectancy as the elite. Although there 
are differences between the group sizes of the various artist types, this is the first time 
that the historical life expectancy of different artists is studied in relation to each other 
and the elite population. However, whether the observed differences are related to the 
practicing of art or due to socioeconomic status, selection effects or other characteristics 
of artists remains to be further studied.
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During the studied period from 1700 to 1899, life expectancy increased for both artists 
and the elite. Possible mechanisms that have driven this increase in life expectancy 
could be improvements in living conditions, better hygiene and public health [30]. 
From 1850 onwards, with the epidemiologic transition, the increase in life expectancy 
is known to be especially driven by improvements in wealth and public health [30]. Up 
to 1850, visual artists were the only artists having a lower life expectancy than the elite 
in our study. Earlier it has been shown that painters have a lower life expectancy than 
sculptors, which was attributed among other factors to differences in exposure to toxic 
materials [15, 31]. This could partly explain the observed lower life expectancy of visual 
artists in our study, since the visual artist group consisted primarily of painters (81.7%). 
Additionally, it is possible that other factors, such as differences in terms of educational 
level, socioeconomic status or familial background could be behind the difference in life 
expectancy between visual artists and other artists groups. 
It is tempting to hypothesize about possible mechanisms behind our findings. 
Socioeconomic status is strongly linked to life expectancy [32]. Even today, rich people 
outlive poor people by seven years in the Netherlands [33]. How socioeconomic status 
was related to life expectancy in the past is however debated [34]. Historical data suggest 
that socioeconomic status was not linked to life expectancy as today [35]. By contrast, 
contemporary data from a rural population in Ghana, have shown that even under those 
adverse conditions, individuals with a higher socioeconomic status have a considerable 
survival advantage [36]. In our dataset, there is no information on the socioeconomic 
status of the individual artists. Little is known in general about the socioeconomic status 
of artists in historical times, but prior to the industrialization artists usually descended 
from middle class families [15,28]. Detailed studies on the socio-economic position of 
visual artists in the first half of the nineteenth century in the cities of Dordrecht and 
The Hague, have confirmed that the majority of the artists were able to live a rather 
comfortable life; the most successful were able to earn an income that was higher than 
that of the middle classes (artisans, merchants, public servants) they originated from 
[37]. This picture is confirmed by the outcome of a study on the socio-economic position 
of the visual artists in the second half of the same century in The Hague and Amsterdam. 
It would seem that in this period the visual artists were quite successful in climbing the 
social ladder [38]. In the 18th century, the income of musicians was not sufficient to make 
a living. Some musicians therefore, additionally worked in other professions too; in our 
study 34% of the acoustic artists were having another profession next to their artistic 
career. Literary artists also belonged to the middle class in economical terms. Only from 
the end of the 19th century onwards, by industrialization of book printing techniques, 
their socioeconomic status improved [39]. 
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The low life expectancy among the middle and lower class has been related to poor 
sanitation, malnutrition, overcrowding, polluted water, less access to health care and 
living in unsafe and unhealthy conditions [40]. It is important in this respect that most 
artists lived in urban areas where their audience and clients lived. Here, poor sanitary 
conditions and epidemics of infectious diseases used to cause high mortality [15]. This 
makes it especially striking that the life expectancy of most artists was similar compared to 
the higher classes with much better living circumstances. After the industrialization, the 
mass production of cheaper products led to an increased access to musical instruments 
for people of lower classes. Additionally, living conditions in the cities deteriorated and 
these processes could have contributed to the lower life expectancy of artists compared 
to the elite born in the period after 1850 until 1900 [41]. 
Others have studied several mechanisms through which artistic creativity could have an 
effect on health and ageing [42-55]. Some have found that art and music interventions 
can enhance bodily control or improve pain management [43]. In addition, it reduces 
stress and anxiety with consequent effects upon heart rate, respiration, blood 
pressure, brain function and immune response [44]. Singing for instance, has been 
found to increase certain chemicals, such as endorphins (natural pain killers) and 
immunoglobulin A (immune function), which enhances the pulmonary work out, oxygen 
intake and increases circulation [45]. Moreover, music distracts one from feelings of 
illness, gives patients sense of control and lowers their blood pressure [43-45]. Also, 
music has been found to boost the immune function [46], increase cognitive function 
[47] and improve memory performance [48], concentration and attention [48]. Music 
increases physical performance by increasing psychological arousal, reduces feelings of 
fatigue and improves motor coordination [49, 50]. Studies on visual arts revealed similar 
results, such as reducing anxiety, improving vital signs, diminished cortisol levels related 
to stress and improved sleeping patterns [51, 52]. In addition, creative writing such as 
poetry has been found to have beneficial psychological effects on coping mechanisms for 
depression and increases the likelihood that patients can stop their antidepressants [53]. 
Finally, it can boost the immune system and improve pain control [54, 55]. 
 
We analysed a unique cohort with artists from three different disciplines over a long time 
span from 1700 till the end of the next century. The Low Countries form an interesting 
case to study the effect of arts because of their rich tradition in artistic creativity [15]. 
A limitation of our study is that the historical records contained very few women and 
hence, we have only studied the life expectancy in men. Furthermore, it is possible that 
our database contains only the artists who survived long enough to have the opportunity 
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to become well known and for that reason also well documented. In this case our 
observations would be partly explained by survivor treatment selection bias. However, 
we have tried to overcome this problem by studying life expectancy at age 50. 
All in all, we have found that in cohorts born before 1850, acoustic and literary artists had 
comparable life expectancy as elite groups, despite belonging to middle socioeconomic 
class and living in urban areas with poor living conditions. Only visual artists had a 
lower life expectancy compared to the elite. From our historical analysis, we hypothesize 
several mechanisms through which artistic creativity could influence ageing and life 
expectancy. These hypotheses, however, should be formally tested before any definite 
conclusions about the effects of arts on ageing can be drawn.
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In this thesis, we studied the compression and plasticity of old-age mortality during 
the epidemiologic transition. We focussed on the Netherlands, Japan and Ghana, three 
countries that have all experienced a different epidemiologic transition. The Netherlands 
has experienced a classical epidemiologic transition, in which all stages were sequential. 
Japan is the best known example of an accelerated classic epidemiologic transition, which 
only took about fifty years. Ghana is currently experiencing a protracted epidemiologic 
transition, in which the different stages overlap. There are several conclusions we can 
draw from our studies on old-age mortality trends in these epidemiologic transitions.
MAIN FINDINGS
The first two chapters describe mortality patterns in rural Ghana followed up for a 
period of nine years. In Chapter two we examined the role of socioeconomic status and 
water source on mortality and fertility decline during the epidemiologic transition. We 
found that both mortality and fertility declined, accompanied by a shift in the causes 
of death, which changed from primarily infectious causes to non-infectious. However, 
both the decline in mortality and fertility were found to be similar in the poor and rich 
groups as well as in the groups which have access to (un)safe water source. Hence there 
must be other determinants that drive the epidemiologic transition in this rural area in 
Ghana. These findings are in line with the current theories on determinants that drive 
the protracted transition in rural African countries. Some have shown that public health 
interventions, such as immunization or maternal and child health programs are the main 
drivers behind the protracted epidemiologic transition.
In the following chapter three we studied the seasonal variation in mortality in rural 
Ghana. We found that mortality due to infectious diseases occurred mainly in September 
during the wet season, while mortality due to non-infectious causes occurred mostly 
in April during the dry season. This indicates that during the epidemiologic transition 
mortality not only shifts from child to old-age mortality, and from infectious to non-
infectious causes of death, but that the distribution of deaths over the seasons probably 
changes as well. This is important for future public health interventions in rural Africa. 
Next to changes in seasonal variation in mortality during the epidemiologic transition, we 
studied the process of the compression of mortality during the epidemiologic transition 
in Japan and the Netherlands in chapter 4. Our observations show a continuing shift of 
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mortality to higher ages, together with a compression of the age-at-death distribution 
that appears to have reached a limit, in both Japan and the Netherlands. The observed 
limit to the compression of mortality is in line with the current theory on ageing, as 
a stochastic accumulation of damage over time. Due to the stochastic element in the 
ageing process, there will always be variation in the rate of ageing and hence, the limit to 
the compression of mortality has to be above zero. Accordingly, we have observed that 
the limit of mortality compression is reached at an age-band of 12 years in which fifty 
percent of the annual mortality occurs. This indicates that differences in lifespan within 
a homogeneous population can never become less than the age-band when mortality 
compression has reached a limit. Ultimately this limit is determined by the random 
variation in the pace of ageing. 
In addition to the compression of mortality, we examined the compression of morbidity in 
chapter five. Now that life expectancy is continuously on the rise, it is questioned whether 
the extra years are lived in good or in ill health. Analysis of the trajectories in healthy life 
expectancy revealed that during the epidemiologic transition, there has been an expansion 
of morbidity in the Netherlands. Hence, individuals live with chronic diseases for more 
years, which could reflect both early diagnosis and changed lifestyles. By contrast, we 
observed a compression of disability in both women and men, as life expectancy without 
disabilities increased parallel to the increase in life expectancy. Overall, by screening for 
chronic diseases and proper treatment of for instance hypertension, we postpone or 
even prevent disability, including in this case cardiovascular disease, and increase life 
expectancy. We did observe sex differences in life expectancy which persisted up to old 
age. At the highest ages however, men and women can expect a similar number of years 
of healthy life expectancy. At the end of life there remains a period of disability that can 
be postponed, but not further compressed. Hence, the need for care will be remain to be 
concentrated at the end of life. In chapter six we discuss the societal implications of this 
and argue that it is time for people to realise that they can foresee a healthier and longer 
life and that they have to plan their life course accordingly. 
In Chapter seven we study the plasticity of mortality at old age in a natural experiment in 
Japan. In general, studying factors that impact directly on old-age mortality is challenging. 
In most countries, improvements in the environment and living conditions that have 
occurred during the epidemiologic transition, has changed relatively smoothly over time. 
The case of Japan is exceptional because of the relatively adverse living conditions for 
the general population during the first half of the 20th century, after which an accelerated 
transition resulted in rapid improvements after 1950. Studying different birth cohorts in 
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Japan, that were exposed to different extents to the rapid improvements, we have shown 
that environmental improvements in late life can reduce old-age mortality independent 
of exposures in early life. This result indicates that mortality remains highly plastic up to 
old age. Modern preventive strategies however, are mostly focused on the young. Our 
observations from Japan strengthen the notion that preventive measures later in life can 
also have great potential benefit. 
In chapter eight, we have studied whether or not high intensity physical exercise has a 
health benefit over low intensity exercise in a cohort of former Olympic athletes. Here we 
show that athletes from disciplines with high intensive exercise have a similar mortality 
risk when compared to athletes from disciplines with low intensity exercise. Rowing for 
instance, has no added benefit to reduce mortality risk when compared to playing golf. 
However, one should have a moment of caution before engaging in disciplines with risk 
of bodily collision and or physical contact, since athletes from such disciplines suffered 
an increased mortality risk, which persisted up to old age. 
Finally, in chapter nine, we studied the life expectancy of historical artists compared to 
the elite in the Low Countries. These data revealed that although artists belonged to the 
middle socioeconomic class, they had a similar life expectancy when compared to the 
elite of that time. We hypothesize several mechanisms through which artistic creativity 
could influence life expectancy. However, these hypotheses should be formally tested 
before any definite conclusions on effects of the arts on life expectancy can be drawn.
Overall, when countries shift from a pre- to a post-transitional stage, mortality decreases 
and an increasing number of people live up to old age. In addition, mortality is compressed 
to a narrower age interval in which most of the annual deaths occur. This compression of 
mortality reaches a limit as soon as countries enter the post-transitional era. Furthermore, 
during the last stage of the epidemiologic transition, with the appearance of ‘diseases 
of affluence’, we have observed an expansion of morbidity and more years are lived with 
chronic diseases. By contrast however, life expectancy without disability is increasing 
parallel to the increase in life expectancy indicating a compression of disability. Due 
to earlier diagnosis more years are lived with chronic diseases, but this allows for early 
treatment that in the end postpones or even prevents disability. In general, mortality 
remains highly plastic up to old age, as indicated by the continuous rise of life expectancy 
and the shift of the age-at-death distribution towards higher ages.
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Strengths and weaknesses 
Studies on the plasticity and compression of old-age mortality have been primarily 
demographic and descriptive in nature, presenting time trends only.[1-6] In this thesis 
we not only studied time trends, but also linked mortality changes to life expectancy. 
Additionally, we have studied the trends in old-age mortality in the theoretical framework 
of the biology of ageing and we have tried to get further insight in the underlying 
mechanisms of both the plasticity and compression of mortality. 
 
There are also limitations of the studies in this thesis. In general, causal relationships 
between determinants and outcomes are best studied using an experimental study design 
with a specific intervention.[7] We have tried to get a better understanding of specific 
determinants and the underlying process of mortality changes, based on experiments 
of nature. Hence, it is hard to draw any definite conclusion about causal relationships 
between the various determinants of old-age mortality. Experiments from nature do 
allow us to test some pseudo-interventions that are not possible in normal experiments. 
Another limitation is that we have studied the mortality patterns in three countries only. 
However, the Netherlands, Japan and Ghana are unique cases, providing an example of 
different epidemiologic transitions. 
IMPLICATIONS FOR SOCIETY
The plasticity of mortality as we have observed during the epidemiologic transition 
has resulted in a rising number of people that have the privilege to live up to old age 
while maintaining good health. However, this trend can only continue when we adapt 
our society to accommodate our growing elderly population. This comes with several 
societal challenges in terms changes in formal and informal care, health care costs and 
pension policies. Some of the implications will be discussed below. 
Dependency ratio
The epidemiologic transition has led to both low fertility and low mortality, which has 
resulted in ageing populations, especially in today’s western societies.[8-10] The age 
composition in these populations has changed from predominantly young individuals 
towards an age composition in which the proportion of children, adults and elderly is 
almost equal.[10,11] This is one of the most common starting points for policy makers 
and is often measured as the dependency ratio [12-16]. This ratio is an age-based 
indicator for the burden on the productive labour population and is given as the ratio 
of non-productive per productive individual. Based on the observations in our studies, 
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however, we have several remarks concerning the dependency ratio as a measure for 
policy makers. First, while the old-age dependency ratio is increasing, one should not 
overlook that the total dependency ratio is influenced by the youth dependency ratio as 
well. The latter ratio (0-19 years divided by 20-64 years) has decreased during the last 50 
years and will further decline in the future. The old-age dependency ratio (65+ divided 
by 20-64 years) has increased and is expected to do so in the coming decades. The total 
dependency ratio however, has not increased, and has in fact slightly decreased.[10,11] 
A second reason dependency ratios are inaccurate is because it categorizes all people 
aged 65 years or older as dependent. As it is an indicator based solely on chronological 
age, it overlooks that not all individuals above age 65 are dependent. Especially as we 
have shown that with the shift of mortality to higher ages, life expectancy in good health 
and without disabilities also increases. Policy makers should take this into account when 
using the total dependency ratio as a starting point for future policies of formal and 
informal care, health care costs and pension systems. 
Health care costs 
The average level of long-term care expenditure has been shown to rise with age [13]. It 
is questionable however, whether an ageing population is the major driver of the ever 
increasing health care expenditure. For example, it has been shown that health care costs 
are concentrated in the last years of life.[17,18] This is in line with our findings of a fixed 
period of disability at the end of life that cannot be further compressed. This implies that 
irrespective of how old one gets, the disability burden and the highest health care costs 
will be in the last year of life. In addition, the demand for health care will be postponed 
to higher ages. All in all, although higher ages are known to be associated with higher 
long-term care expenditure, it is not the main explanation for the rise in health care costs. 
Alternatively, there has been an expansion in the use of medical technology during the last 
decades. These technical innovations have fostered the rise in health care expenditure 
and hence have played a major role in the overall increase of health care costs.[19,20] 
Pension policies
We have shown that human lifespan is continuously on the rise. This plasticity not only 
results in longer lives for individuals, but also for more people reaching old age. This 
has several consequences for many countries that offer their older citizens financial 
security through pension systems. In a social pension system, financial resources are 
redistributed from the working population to the retired population.[10] In other words, 
as the old-age dependency ratio increases, a smaller working population is responsible 
for a relatively larger retired population. This will become a major burden for pension 
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systems. Although life expectancy and healthy life expectancy are still increasing, many 
countries still have a relatively early withdrawal from the labour market, at an average 
age below 60.[11-13] Increasing pension age not only helps to reduce the burden for 
pension systems, but it also results in a larger labour force.[13] Most countries however, 
are hesitant to take the necessary measures in order to achieve this.[14] It is now time to 
act and make sustainable policies that meet the needs from ageing societies. 
IMPLICATIONS FOR MEDICINE
Next to the societal implications of the plasticity of old-age mortality, there are also some 
specific implications for medicine. Below we will briefly discuss the implications in terms 
of ‘evidence-based medicine’, ‘evidence-based prevention’, health care structure and 
medical education. 
Evidence-based medicine
Now that in most countries more and more people reach old age, we should rethink 
‘evidence-based medicine’. Currently the evidence is still based on studies in middle 
aged adults, with a single disease. This is problematic in two ways. First, most elderly 
have multiple diseases at the same time, which brings new challenges.[24] There are 
little to no randomized clinical trials including elderly with multimorbidity.[25] Second, 
ageing comes with some physiological changes that change the pharmacokinetics and 
pharmacodynamics.[26] Consequently, known effective treatments at middle age might 
lead to different health outcomes at old age. Hence, future research should focus on 
clinical trials with elderly having multimorbidity in order to get evidence-based medicine 
for this group and address the current needs of our society. Although our studies 
indicated a continuous rise in life expectancy and healthy life expectancy, this can only 
continue to increase if we adapt our medicine to fit the new older patient population. It is 
important to mention here that the primary aim should be to improve quality of life and 
that only as a result life expectancy will increase. 
 
Evidence-based prevention
We have observed that mortality remains highly plastic up to old age. This indicates 
that in addition to life-course approaches to improving health and well-being, preventive 
measures at older ages can deliver great benefits. Apart from physical exercise, evidence 
for effective preventive measures is poor, especially when it comes to prevention at old 
age.[27] Since most age-related diseases are highly determined by life-style, development 
of ‘evidence-based prevention’ for elderly should be primary objective for ageing societies 
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The observed plasticity of ageing should be encouraging to study specific preventive 
measures. This urgently needs to be placed on the research agenda[27]. 
Health care structure
With the increase in life expectancy, there has been an expansion of chronic diseases, 
which increases the need for long-term care. In addition, there has been an increase in 
the prevalence of multimorbidity, which is becoming the norm rather than the exception. 
Nowadays, health care structure is insufficient and not adapted to the current older 
patient population. Current health care is mainly focussed on acute problems and short-
term solutions. Chronic diseases demand for long-term care with active involvement 
of patients themselves. In the current system, patients with multiple chronic diseases 
do not receive optimal care. It has been shown that enhancing self-management of 
chronically ill patients not only leads to patients being in control of their own health, 
but it also improves health care outcomes.[28] In addition, formal care should shift 
towards a multidisciplinary approach, where different specialists work together as a 
team. Multimorbidty requires a patient-centred approach with a multidisciplinary team 
that provides holistic care. Overall, we have to rearrange our health care structure in a 
way that patients become actively involved as being their own health manager and formal 
care is patient-centred with a holistic approach.
Medical Education
Due to the plasticity of mortality, the proportion of elderly patients has increased rapidly 
during the last decades. Since this trend is expected to continue, future medical doctors 
should be prepared for a patient population containing predominately elderly. However, 
medical education on the treatment of elderly patients is currently unsatisfactory.[29] 
Both medical students and current medical specialists are trained to treat patients 
with single diseases and hence, are not prepared for the largest group of their patient 
population. In order to improve medical care for the elderly, it is essential that all health 
care professionals receive a basic training about the complex care for elderly in terms of 




Overall, our studies show the plasticity of old-age mortality. There is no indication that 
we have reached the limits of this plasticity, which is an encouraging finding. Hence, 
we can be optimistic about the future, but we also have to adapt to the new reality that 
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NEDERLANDSE SAMENVATTING
DE COMPRESSIE EN PLASTICITEIT 




Gedurende de laatste eeuw is de levensverwachting bij geboorte wereldwijd gestegen.
[1] Tot op heden is er nog geen limiet en zet deze trend zich voort.[2] Dit roept veel 
vragen op over hoe de toekomst eruit zal zien. Nemen binnen een land de verschillen 
in levensverwachting toe of af? Betekent langer leven ook langer gezond leven? Kunnen 
we sterfte op hoge leeftijd nog verder terugdringen? In dit proefschrift proberen we 
antwoorden te vinden op dergelijke vragen, door de mechanismen die de drijfveer zijn 
achter de continue sterftedaling beter te begrijpen. In het bijzonder bestuderen we 
de compressie en plasticiteit van sterfte op hoge leeftijd die hebben plaatsgevonden 
gedurende de epidemiologische transitie. Hieronder volgt een korte introductie over 
zowel de epidemiologische transitie als de compressie en plasticiteit van sterfte. 
 
De theorie over de verschillende stadia van de epidemiologische transitie is voor het eerst 
beschreven door Omran in 1971.[3] Tijdens deze transitie is er een sterfte daling, gevolgd 
door een daling in vruchtbaarheid. Daarnaast is er een verschuiving in de samenstelling 
van doodsoorzaken van infectieus naar meer niet-infectieuze doodsoorzaken 
veroorzaakt door chronische ziekten. De veranderingen in sterfte en vruchtbaarheid 
tijdens de epidemiologische transitie kunnen op verschillende manieren verlopen door 
de tijd. In het klassieke model van de transitie zoals deze is verlopen in de huidige post 
transitionele landen, verlopen de verschillende stadia van de epidemiologische transitie 
sequentieel. Daarnaast heeft in sommige landen de epidemiologische transitie versneld 
plaatsgevonden ten opzichte van het klassieke model. Japan is hiervan het meest bekende 
voorbeeld, waar de gehele transitie heeft plaats gevonden in minder dan vijftig jaar.[4] In 
huidige ontwikkelingslanden in transitie vindt er juist een vertraagde epidemiologische 
transitie plaats, waarin ook verschillende stadia met elkaar overlappen.[3]
 
Gedurende de epidemiologische transitie neemt de levensverwachting toe en groeit het 
aantal mensen dat een hoge leeftijd bereikt. Dit gaat gepaard met een afname in de 
spreiding rondom de leeftijd waarop de meeste sterfte plaats vindt in een bepaald jaar. 
Dit wordt de compressie van sterfte genoemd.[5] Maximale compressie van sterfte zou 
betekenen dat alle jaarlijkse sterfte op dezelfde leeftijd plaats vindt. Daar tegenover staat 
minimale compressie, wat inhoudt dat de kans om te overlijden in een bepaald jaar 
voor alle leeftijden gelijk is.[6] Gedurende de afgelopen eeuw is er sprake geweest van 
compressie, maar onduidelijk is hoever deze compressie zich doorzet.[7-9] Naast de 
compressie van sterfte is er ook de compressie van ziekte. Dit gaat over de vraag of met 
het stijgen van de levensverwachting er jaren in goede of slechte gezondheid bij komen.
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[10,11] Tot op heden is er geen consensus bereikt over het verloop van de compressie 
van ziekte en sterfte. 
 
Als laatste belichten we de plasticiteit van sterfte op hoge leeftijd. Het is reeds bekend 
dat een vroege leefomgeving van belang is voor het risico op ziekten later in het 
leven.[12] Slechte voeding of hoge blootstelling aan infectieziekten vroeg is het leven, 
zijn geassocieerd met hogere sterfte kansen op latere leeftijd.[13,14] Er is echter geen 
overeenstemming over het effect van de omgeving op hoge leeftijd.[15-18] Veel studies 
beschrijven dat het verbeteren van de omgeving op hoge leeftijd geen gezondheidswinst 
meer oplevert.[16,17] Dat staat haaks tegenover anderen die laten zien dat sterfte ook op 
hoge leeftijd nog verder te reduceren is.[18] In hoeverre sterfte nog beïnvloedbaar is op 
hoog leeftijd, is van groot belang in het kader van preventie.[19] 
 
Het doel van dit proefschrift is dan ook om meer inzicht te krijgen in het intrinsieke 
proces van compressie en de plasticiteit van sterfte op hoge leeftijd gedurende de 
epidemiologische transitie. We doen dit door de sterfte te bestuderen in Ghana, 
Nederland en Japan, drie landen die de epidemiologische transitie verschillend hebben 
doorlopen. 
 
OVERzICHT VAN DIT PROEFSCHRIFT
Hoofdstuk één is een algemene introductie van dit proefschrift waarin de theorie over 
de epidemiologische transitie en de begrippen compressie en plasticiteit van sterfte op 
hoge leeftijd worden geïntroduceerd. In de volgende hoofdstukken bestuderen we de 
epidemiologische transitie in Ghana. Om te beginnen met hoofdstuk twee, waarin we de 
rol van sociaal economische status en drink water hebben bestudeerd op de afname van 
sterfte en vruchtbaarheid gedurende de epidemiologische transitie. Deze twee factoren 
hebben een belangrijke rol gespeeld bij de afname in sterfte en vruchtbaarheid tijdens de 
traditionele epidemiologische transitie in westerse landen. Onze observaties in Ghana 
laten zien dat er een epidemiologische transitie gaande is in het onderzoeksgebied. 
Zowel sterfte als vruchtbaarheid zijn sterk gedaald gedurende de follow-up periode van 
2002 tot 2011. Daarnaast heeft er een verschuiving plaats gevonden in de samenstelling 
van doodsoorzaken, die werden eerst gedomineerd door infectieziekten, maar nu 
door niet-infectieuze oorzaken. In tegenstelling tot de traditionele transitie in westerse 
landen, was er geen verschil in afname van sterfte of vruchtbaarheid tussen mensen met 
een hoge versus lage sociaaleconomische status en ook niet tussen de groepen met 
toegang tot veilig of onveilig drinkwater. Er zijn dus andere factoren die de ‘vertraagde’ 




In hoofdstuk drie hebben we de variatie van sterfte over de seizoenen bestudeerd in Ghana. 
De grootste piek in sterfte door infectieuze oorzaken was in september gedurende het 
regenseizoen, terwijl de grootste piek met sterfte door chronische aandoeningen te zien 
was in April, gedurende het droge seizoen. Deze bevindingen laten zien dat gedurende 
de epidemiologische transitie, de sterfte niet alleen verschuift van jong naar oud en van 
infectieuze naar meer chronische doodsoorzaken, maar dat de verdeling van sterfte over 
de seizoenen mogelijk ook verschuift.
 
Naast de epidemiologische transitie in Ghana, hebben we de compressie van sterfte 
bestudeerd tijdens de transitie in Nederland en Japan in hoofdstuk vier. Onze bevindingen 
in Nederland en Japan laten zien dat met een toename van de levensverwachting, de 
spreiding van sterfte over de leeftijd comprimeert. Met andere woorden, de spreiding 
in levensduur tussen mensen is afgenomen. Daarnaast hebben we gevonden dat er 
een limiet is bereikt aan de compressie van sterfte zowel in Nederland als Japan. Voor 
beide landen ligt dit limiet op een spreiding van 12 jaar rondom de leeftijd waarop de 
meeste mensen komen te overlijden in dat jaar. Dit is in lijn met de huidige theorie over 
veroudering, dat gezien wordt als een stochastische opeenstapeling van schade over 
de tijd. De snelheid van deze opeenstapeling kan gezien worden als de snelheid van 
het verouderingsproces. Doordat veroudering een stochastisch proces is zal er altijd 
verschil blijven bestaan in de snelheid waarmee mensen verouderen. De compressie van 
sterfte kan dus nooit gecomprimeerd worden tot nul. In een homogene populatie wordt 
de limiet van sterfte compressie dus bepaalt door de resterende variatie in de snelheid 
waarmee mensen verouderen. 
 
Naast de compressie van sterfte, bestuderen we in hoofdstuk vijf de compressie van 
ziekte. Top op heden is er nog geen afname in de snelheid waarmee de levensverwachting 
stijgt. Dit roept de vraag op of de extra jaren die we leven in goede of slechte gezondheid 
worden doorgebracht. Onderzoek naar de trends in ‘gezonde’ levensverwachting in 
Nederland laat zien dat meer jaren geleefd worden met chronische ziekten, maar dat de 
jaren die we leven zonder lichamelijke beperkingen en de jaren die we leven in goed zelf-
ervaren gezondheid parallel stijgen met de stijging in levensverwachting. De toename van 
het aantal jaren met chronische ziekten kan deels verklaard worden door een toename 
in welvaartsziekten als diabetes en hoge bloeddruk, maar ook deels door verbetering in 
vroege opsporing van dergelijke ziekten om zo middels goede behandeling de lichamelijke 
beperkingen te voorkomen. Deze studie laat daarnaast zien dat er verschillen zijn tussen 
mannen en vrouwen. Mannen hebben een lagere levensverwachting dan vrouwen, 
maar leven proportioneel meer jaren zonder chronische ziekten. Op 80 jarige leeftijd 
153
Nederlandse samenvatting
hebben mannen nog steeds een lagere levensverwachting, maar bestaat er geen verschil 
meer in gezonde levensverwachting ten opzicht van de vrouwen. Voor zowel mannen 
als vrouwen geldt dat er aan het einde van het leven een periode van kwetsbaarheid 
blijft bestaan. Deze periode wordt wel steeds verder opgeschoven naar hogere leeftijden, 
maar niet verder verkort. Onze observaties sluiten goed aan bij de eerdere bevinding dat 
de meeste kosten met betrekking tot de gezondheid in de laatste twee jaar van het leven 
worden gemaakt. 
 
Hoofdstuk zes is bouwt voort op het vorige hoofdstuk. Hierin bepleiten we dat het tijd 
is voor mensen om zich te realiseren dat er niet alleen een langer, maar vooral ook een 
gezonder leven in het vooruitzicht ligt. Het is van belang om dat we ons hierop instellen 
en ons leven en de maatschappij daarop aanpassen. 
 
De toename in levensverwachting zoals besproken in voorgaande hoofdstukken geeft 
al aan dat sterfte op hoge leeftijd plastisch is. De vraag die nog rest is of dat door 
verbeterde omstandigheden vroeg in het leven komt, of dat ook een betere omgeving op 
hoge leeftijd daaraan nog heeft bijgedragen. Op deze vraag wordt ingegaan in hoofdstuk 
zeven. Het is reeds bekend dat de vroege leefomgeving van belang is voor het risico van 
ziekten op latere leeftijd. Onduidelijk is of verandering van omgeving op hoge leeftijd 
nog kan resulteren in gezondheidswinst. Om dit te onderzoeken hebben we gekeken 
naar de sterftetrends in Japan. Japan is uniek, omdat het een versnelde epidemiologische 
transitie heeft doorgemaakt. Cohorten geboren tussen 1900 en 1920 hebben eenzelfde 
ongunstige leefomgeving gehad gedurende de eerste levensperiode, maar zijn op latere 
leeftijd blootgesteld aan een sterk verbeterde leefomgeving. Het geboortecohort van 
1920 heeft het langste kunnen profiteren van de betere leefomstandigheden op hoge 
leeftijd hadden dan ook de lagere sterfte op hoge leeftijd ten opzicht van vroegere 
geboortecohorten. Daarnaast laat deze studie zien dat zelfs tot op hoge leeftijd 
sterfte plastisch blijft, een betere leefomgeving resulteert in lagere sterfte. Dit geeft 
weer dat preventieve maatregelen die geïntroduceerd worden op hoge leeftijd nog 
gezondheidswinst kunnen opleveren.
 
Als laatste in hoofdstuk acht wordt ingegaan op lichamelijke activiteit, één van de 
belangrijkste determinanten van gezondheid en sterfte. Vaak wordt gedacht dat meer 
lichamelijke activiteit altijd beter is voor gezondheid en sterftekansen. De meeste studies 
waarin dit is onderzocht hebben atleten met de algemene bevolking vergeleken. Dit geeft 
wel antwoord op de vraag of atleten langer leven dan de algemene bevolking, maar niet 
of dat door de mate van lichamelijke inspanning komt. De algemene bevolking bevat 
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immers ook mensen met aangeboren ziektes, waar atleten vaak een selectie zijn van 
de meest fitte mensen in een populatie. In onze studie hebben we daarom gekeken 
naar sterfte binnen een groep oud Olympisch atleten uit verschillende disciplines met 
een lage, middelmatige of hoge mate van lichamelijke intensiteit. Hieruit is naar voren 
gekomen dat atleten uit een discipline met een hoge mate aan lichamelijke intensiteit 
geen extra overlevingsvoordeel hebben ten opzichte van atleten uit een discipline met 
lage lichamelijke intensiteit. Olympisch roeiers of marathonlopers hebben bijvoorbeeld 
geen lagere sterftekans vergeleken met Olympische golfers. Verder is gebleken dat het 
beoefenen van een sport met kans op lichamelijke botsingen of lichamelijk contact een 
verhoogd sterfterisico met zich mee brengt ten opzichte van atleten die actief zijn in 
sporten zonder deze risico’s. Voorbeelden van dergelijke risicosporten zijn bijvoorbeeld 
turnen, voetbal en polo ten opzichte van zwemmen of tennis. Interessant was dat dit 
hogere sterfterisico ook op hogere leeftijd, na het vijftigste levensjaar bleef bestaan.
 
In hoofdstuk negen sluiten we af door de belangrijkste conclusies uit dit proefschrift 
samen te vatten en de mogelijke implicaties van deze bevindingen te bespreken. 
 
CONCLUSIE EN IMPLICATIES 
Gedurende de epidemiologische transitie is er een daling van sterfte en vruchtbaarheid 
en neemt het aantal mensen dat een hoge leeftijd bereikt snel toe. Dit gaat gepaard met 
compressie van sterfte tot een kleiner leeftijds-interval dat uiteindelijk een limiet bereikt. 
Tegelijkertijd is er nog geen afname in de snelheid waarmee de levensverwachting stijgt 
en hoewel meer jaren worden doorgebracht met chronische ziekten, leven we langer 
in goed zelf-ervaren gezondheid en langer zonder lichamelijke beperkingen. Zelfs op 
hoge leeftijd blijft sterfte plastisch en dus beïnvloedbaar. Het blijft onmogelijk om de 
toekomst te voorspellen, maar op basis van de historische sterfte trends kunnen we wel 
scenario’s schetsen op basis van waarschijnlijkheid. 
 
Het is een groot voorrecht dat op dit moment zoveel mensen een hoge leeftijd bereiken 
in goede gezondheid. Dat dit ook nieuwe uitdagingen met zich mee brengt spreekt voor 
zich.[20,21] Één van de grootste angsten wellicht is de druk op de arbeidsmarkt.[23] De 
leeftijdssamenstelling in de populatie is drastisch gewijzigd. Voor het eerst draagt het 
aantal ouderen proportioneel evenveel bij als het aantal volwassenen en jongeren.[21,23] 
Onderbezetting en werkeloosheid maken de arbeidsproductiviteit kwetsbaar.[24,25] Op 
dit moment is de leeftijd waarop mensen zich terugtrekken van de arbeidsmarkt gemiddeld 
lager dan 60 jaar in de meeste landen.[26] Het verhogen van de pensioenleeftijd zal niet 
155
Nederlandse samenvatting
alleen de druk op de pensioenvoorzieningen reduceren, het zal ook bijdragen aan de 
onderbezetting op de arbeidsmarkt in de nabije toekomst.[22] Het is van groot belang 
om onze maatschappij zo in te richten dat het groeiende aantal ouderen langer actief kan 
blijven en op die manier ook langer een bijdrage kan blijven leveren.
 
Sterfte blijkt tot op hoge leeftijd beïnvloedbaar. Dit is belangrijk in het kader van preventie. 
Op dit moment is er nog weinig aandacht voor preventieve maatregelen gericht op 
ouderen. Alhoewel het aantal ouderen snel toeneemt, is er binnen de geneeskunde 
nog een gebrek aan zo genoemde ‘evidence based medicine’ om ouderen optimaal te 
kunnen behandelen of preventieve maatregelen in te voeren. In dit kader is het van 
belang om te noemen dat preventie en behandeling van ziekte anders is bij ouderen 
dan voor volwassenen van middelbare leeftijd.[27,28] Ouderen hebben vaak meerdere 
ziekten tegelijk, terwijl volwassenen van middelbare leeftijd vaak maar één enkele ziekte 
tegelijk hebben.[27] Verder verandert met het ouder worden de fysiologie in het menselijk 
lichaam, waardoor ook de behandeling soms een ander aanpak vraag dan bij mensen 
van middelbare leeftijd.[28] In de preventie en behandeling van ziekten bij ouderen valt 
nog veel winst te behalen.[30] 
 
Uiteindelijk hebben we laten zien dat ziekte en sterfte veranderlijk zijn en dat tot op 
hoge leeftijd blijven. Laat dit een aanmoediging zijn voor zowel de maatschappij als elk 
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